WO2003097808A9 - Automated system for isolating, amplyifying and detecting a target nucleic acid sequence - Google Patents

Automated system for isolating, amplyifying and detecting a target nucleic acid sequence

Info

Publication number
WO2003097808A9
WO2003097808A9 PCT/US2003/015602 US0315602W WO03097808A9 WO 2003097808 A9 WO2003097808 A9 WO 2003097808A9 US 0315602 W US0315602 W US 0315602W WO 03097808 A9 WO03097808 A9 WO 03097808A9
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
sample
interest
extractor
component
Prior art date
Application number
PCT/US2003/015602
Other languages
French (fr)
Other versions
WO2003097808A3 (en
WO2003097808A2 (en
Inventor
Thomas Fort
Matthew Collis
Bradley Thomas
Timothy Hansen
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BRPI0310060A priority Critical patent/BRPI0310060B8/en
Priority to ES03728991.5T priority patent/ES2594333T3/en
Priority to JP2004506467A priority patent/JP4532264B2/en
Priority to EP03728991.5A priority patent/EP1506413B1/en
Priority to AU2003233555A priority patent/AU2003233555B2/en
Priority to MXPA04011083A priority patent/MXPA04011083A/en
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Priority to KR10-2004-7018515A priority patent/KR20050008720A/en
Priority to CA2483694A priority patent/CA2483694C/en
Publication of WO2003097808A2 publication Critical patent/WO2003097808A2/en
Publication of WO2003097808A9 publication Critical patent/WO2003097808A9/en
Publication of WO2003097808A3 publication Critical patent/WO2003097808A3/en
Priority to NO20045307A priority patent/NO20045307L/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0099Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor comprising robots or similar manipulators
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50855Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates using modular assemblies of strips or of individual wells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0829Multi-well plates; Microtitration plates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00346Heating or cooling arrangements
    • G01N2035/00356Holding samples at elevated temperature (incubation)
    • G01N2035/00366Several different temperatures used
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/04Details of the conveyor system
    • G01N2035/0401Sample carriers, cuvettes or reaction vessels
    • G01N2035/0403Sample carriers with closing or sealing means
    • G01N2035/0405Sample carriers with closing or sealing means manipulating closing or opening means, e.g. stoppers, screw caps, lids or covers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1009Characterised by arrangements for controlling the aspiration or dispense of liquids
    • G01N2035/1025Fluid level sensing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N2035/1027General features of the devices
    • G01N2035/1048General features of the devices using the transfer device for another function
    • G01N2035/1053General features of the devices using the transfer device for another function for separating part of the liquid, e.g. filters, extraction phase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0098Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/026Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations having blocks or racks of reaction cells or cuvettes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/028Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations having reaction cells in the form of microtitration plates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1065Multiple transfer devices
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1065Multiple transfer devices
    • G01N35/1074Multiple transfer devices arranged in a two-dimensional array
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Definitions

  • the invention is related to the detection of nucleic acids. More particularly, the invention is related to a system and method for the isolation, amplification and detection of targeted nucleic acids in a fully automated and integrated system that comprises a pipetter, extractor and an assay reader, as well as many other devices, to detect the targeted nucleic acids.
  • a pipetter, extractor and an assay reader as well as many other devices, to detect the targeted nucleic acids.
  • nucleic acid sequencing direct detection of particular nucleic acids sequences by nucleic acid hybridization, and nucleic acid sequence amplification techniques
  • This process generally includes the steps of collecting the cells in a sample tube and lysing the cells with heat and/or reagent(s) which causes the cells to burst and release the nucleic acids (DNA or RNA) into the solution in the tube.
  • the tube is then placed in a centrifuge, and the sample is spun down so that the various components of the cells are separated into density layers within the tube.
  • the layer of the nucleic acids can be removed from the sample by a pipette or any suitable instrument.
  • the samples can then be washed and treated with appropriate reagents, such as fluorescein probes, so that the nucleic acids can be detected in an apparatus such as the BDProbeTec ® ET system, manufactured by Becton Dickinson and Company and described in U.S. Patent No. 6,043,880 to Andrews et al., the entire contents of which is incorporated herein by reference.
  • nucleic acids from cell samples may be generally suitable, such methods are typically time consuming and complex. When performed manually, the complexity and number of processing steps associated with a nucleic acid based assay also introduce opportunities for practitioner error, exposure to pathogens and cross contamination between assays. Furthermore, although the centrifuging process is generally effective in separating the nucleic acids from the other cell components, certain impurities having the same or similar density as the nucleic acids can also be collected in the nucleic acid layer, and must be removed from the cell sample with the nucleic acids.
  • paramagnetic or otherwise magnetic or magnetizable particles are placed in an acidic solution along with cell samples.
  • the cell samples are lysed to release the nucleic acids, the nucleic acids are reversibly bound to the particles.
  • the particles can then be separated from the remainder of the solution by known techniques such as centrifugation, filtering or magnetic force.
  • the particle to which the nucleic acids are bound can then be removed from the solution and placed in an appropriate buffer solution, which causes the nucleic acids to become unbound from the particles.
  • the particles can then be separated from the nucleic acids by any of the techniques described above.
  • Pipette tip detection in this known system is achieved by touching the end of the conductive pipette tip to a grounded conductor.
  • Drawbacks of this approach include the higher cost of conductive pipette tips, and that the method only works effectively with ionic fluids. In other words, if the fluid is non-conductive, it will not provide a suitable electrical path to complete the circuit between the conductors in the pipette tip.
  • a system and method for the measurement of the level of fluid in a pipette tube has been described in U.S. Patent No. 4,780,833, issued to Atalce, the contents of which are herein incorporated by reference.
  • Atake's system and method involves applying suction to the liquid to be measured, maintaining liquid in a micro-pipette tube or tubes, and providing the tubes with a storage portion having a large inner diameter and a slender tubular portion with a smaller diameter.
  • a pressure gauge is included for measuring potential head in the tube or tubes. Knowing the measured hydraulic head in the pipette tube and the specific gravity of the liquid, the amount of fluid contained in the pipette tube can be ascertained.
  • Devices used in molecular biology methodologies can incorporate the pipette device mentioned above, with robotics, to provide precisely controlled movements to safely and carefully move sample biological fluids from one container to another.
  • these robotic devices are capable of coupling to one or more of the aforementioned pipette tips, and employ an air pump or other suitable pressurization device to draw the sample biological fluid into the pipette tips.
  • DNA probes which can identify a specific bacteria by testing for the presence of a unique bacterial DNA sequence in the sample obtained from the patient, has greatly increased the speed and reliability of clinical diagnostic testing.
  • a test for the tuberculosis mycobacterium for example, can be completed within a matter of hours using DNA probe technology. This allows treatment to begin more quickly and avoids the need for long patient isolation times.
  • the nucleic acid sequence separating technique and the pipetting technique described above can be used to prepare samples to be used in conjunction with DNA probe technology for diagnostic purposes.
  • nucleic acid amplification reaction is usually carried out in order to multiply the target nucleic acid into many copies or amplicons.
  • nucleic acid amplification reactions include strand displacement amplification (SDA), rolling circle amplification (RCA), self-sustained sequence replication (3SR), transcription-mediated amplification (TMA), nucleic acid-sequence-based amplification (NASBA), ligase chain reaction (LCR) and polymerase chain reaction (PCR).
  • SDA strand displacement amplification
  • RCA rolling circle amplification
  • 3SR self-sustained sequence replication
  • TMA transcription-mediated amplification
  • NASBA nucleic acid-sequence-based amplification
  • LCR ligase chain reaction
  • PCR polymerase chain reaction
  • Detection of the nucleic acid amplicons can be carried out in several ways, all involving hybridization (binding) between the target DNA and specific probes.
  • Many common DNA probe detection methods involve the use of fluorescein dyes.
  • One detection method is fluorescence energy transfer.
  • a detector probe is labeled both with a fluorescein dye that emits light when excited by an outside source, and with a quencher which suppresses the emission of light from the fluorescein dye in its native state.
  • the fluorescein- labeled probe binds to the amplicons, is extended, and allows fluorescence emission to occur. The increase of fluorescence is taken as an indication that the disease-causing bacterium is present in the patient sample.
  • a single fluorescent label may be employed on the reporter moiety with detection of a change in fluorescence polarization in the presence of the complement of the reporter moiety (see US Patent No. 5,593,867).
  • Non-fluorescent labels are also useful.
  • the reporter moiety may be labeled with a lipophilic dye and contain a restriction site which is cleaved in the presence of the complement of the reporter moiety (see US Patent No. 5,550,025).
  • the reporter probe may be radiolabeled and the products resulting from synthesis of the complement of the reporter moiety may be resolved by electrophoresis and visualized by autoradiography. Immuno logical labels may also be employed.
  • a reporter probe labeled with a hapten can be detected after synthesis of the complement of the reporter moiety by first removing unreacted reporter probe (for example by adapter-specific capture on a solid phase) and then detecting the hapten label on the reacted reporter probe using standard chemiluminescent or colorimetric ELISAs.
  • a biotin label may be substituted for the hapten and detected using methods known in the art.
  • Chemiluminescent compounds which include acridiuium esters which can be used in a hybridization protection assay (HP A) and then detected with a luminometer (see US Patent Nos 4,950,613 and 4,946,958).
  • optical readers and scanners One broad category of detection devices that can be used in the various embodiments of the invention (more fully described in detail below), are optical readers and scanners.
  • an X-Y plate scanning apparatus such as the CytoFluor Series 4000 made by PerSeptive Biosystems, is capable of scanning a plurality of fluid samples stored in an array or plate of microwells.
  • the apparatus includes a scanning head for emitting light toward a particular sample, and for detecting light generated from that sample.
  • the apparatus includes first and second optical cables each having first and second ends.
  • the first ends of the optical cables are integrated to form a single Y-shaped "bifurcated" cable.
  • the scam ing head includes this end of the bifurcated optical cable.
  • the second end of the first optical cable of the bifurcated cable is configured to receive light from a light emitting device, such as a lamp, and the second end of the second cable of the bifurcated cable is configured to transmit light to a detector, such as a photomultipHer tube.
  • the optical head is positioned so that the integrated end of the bifurcated optical fiber is at a suitable position with respect to one of the microwells.
  • the light emitting device is activated to transmit light through the first optical cable of the bifurcated optical cable such that the light is emitted out of the integrated end of the bifurcated optical cable toward the sample well. If fluid sample fluoresces in response to the emitted light, the light produced by the fluorescence is received by the integrated end of the optical fiber and is transmitted through the second optical fiber to the optical detector.
  • the detected light is converted by the optical detector into an electrical signal, the magnitude of which is indicative of the intensity of the detected light.
  • the electrical signal is processed by a computer to determine whether the target DNA is present or absent in the fluid sample based on the magnitude of the electrical signal.
  • This apparatus includes a tray having openings for receiving bottles of fluid samples.
  • the tray includes a plurality of optical fibers which each have an end that terminates at a respective opening in the tray.
  • the tray is connected to a wheel, and rotates in conjunction with the rotation of the wheel.
  • the other ends of the optical fibers are disposed circumferentially in succession about the wheel, and a light emitting device is configured to emit light toward the wheel so that as the wheel rotates, the ends of the optical fibers sequentially receive the light being emitted by the light emitting device.
  • the apparatus further include a light detector having an optical axis aligned with the optical axis of the emitted light. Accordingly, if the sample in the bottle housed in the opening fluoresces due to the excitation light, the light emitted from the sample will transmit through the optical fiber and be detected by the detector.
  • the wheel then continues to rotate to positions where the ends of the other optical fibers become aligned with the optical axis of the light emitter and light detector, and the light emission and detection process is repeated to sample the fluid samples in the bottles housed in the openings associated with those fibers.
  • the system must employ a plurality of light detectors and a plurality of light emitters.
  • These additional components greatly increase the cost of the system.
  • photomultiplier tubes which are generally quite expensive, are often used as light detector units in devices of this type. Hence, the cost of the unit is generally increased if more than one photomultiplier tube is used.
  • devices which employ a single detector e.g., photomultiplier tube
  • a detector apparatus is also described in U.S. Patent No. 4,343,991, to
  • Fujiwara et al. This apparatus employs a single light detector and a plurality of light emitting devices to read a sample on a sample carrier, which is a substantially transparent medium.
  • the plurality of light emitting devices transmit light through corresponding optical fibers.
  • the light emitted by the optical fibers passes through the. carrier and is received by corresponding optical fibers on the opposite side of the carrier.
  • the receiving fibers terminate at a single light detector and the light emitters are operated to emit light at different times.
  • light from only one of the emitters passes through the carrier at any given time and is detected by the detector, which outputs a signal proportional to the intensity of the detected light. Therefore, a single detector can be used to detect light from a plurality of light emitting devices.
  • the intensity of the light is decreased because some of the light is absorbed by the sample.
  • the amount by which the light intensity is reduced is proportional to the concentration of the sample material in the sample. Because the signal output by the detector is proportional to the intensity of the detected light, the sample concentration can thus be determined based on the output signal.
  • Past approaches to automate sample processing were limited to automating portions of the process leaving the remaining tasks to be performed by a technician.
  • many earlier systems employ a manual centrifugation step that requires a technician to load sample tubes into and out of an external centrifuge.
  • Other systems require a technician to transfer extraction products from a nucleic acid extraction instrument to an amplification and/or detection instrument.
  • Cartesian robots For example, certain systems utilize cartesian robots for moving samples from one location to another. As known in the art, cartesian robots can move in X, Y and Z direction, are able to perform straight-line insertions and are easy to program. Cartesian robots have the most rigid robotic structure for a given length, since the axes can be supported at both ends. Due to their rigid structure, cartesian robots can manipulate relatively high loads. This enables them to be used for pick-and-place applications, machine tool loading, and stacking parts into bins. Cartesian robots can also be used for assembly operations and liquid dispensing systems. Examples of such uses occur in laboratory applications (genetic research), or any task that is high volume and repetitive.
  • cartesian robots require a large area of space in which to operate, or, in other words, have a large footprint to workspace ratio.
  • Another disadvantage is that cartesian robots have exposed mechanical elements which are difficult to seal from wet, corrosive or dusty environments, and are difficult to decontaminate.
  • SCARA selectively compliant articulated robot arms
  • an automated system for processing a component of interest contained in a sample comprising a sample rack, adapted for receiving at least one container containing the sample, an extraction device, adapted to extract said component of interest from the sample, a detection device, adapted to detect for the presence of said component of interest extracted by said extraction device, and a robot, adapted to automatically transfer the sample to the extraction device, and to automatically transfer said extracted component of interest from said extraction device to said detection device.
  • the centrifugation step discussed above is eliminated and instead accomplished with the use of a magnetic particle extractor subsystem.
  • Utilization of non-specific nucleic acid capture provides advantages of lower reagent cost and improved robustness relative to more complex specific capture systems.
  • the low cost of the non-specific capture particles (iron oxide) allows flexibility to increase the capture matrix and scale binding capacity without significantly impacting cost.
  • SCARA industrial grade robotic arm that provides accurate, repeatable and reliable positioning of the pipetter as opposed to laboratory liquid handling robotic platforms that use less reliable robotic components.
  • Fig. 1 illustrates a known method for manually preparing multiple specimen samples for the isolation, amplification and detection of targeted nucleic acid sequences
  • FIG. 2 illustrates a perspective view of an automated multiple specimen preparation system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention
  • FIG. 3 illustrates an internal view of the fully integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Fig. 2 in accordance with an embodiment of the invention
  • FIG. 4 illustrates a system block diagram of the major components of a fully integrated and automated multiple specimen system as shown in Fig. 2 and more fully described in reference to Fig. 3 and related figures;
  • FIG. 5 illustrates a perspective view of a SCARA robotic arm used in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention
  • Figs. 6 and 7 illustrate different perspective views of a six channel pipetter assembly used in the integrated and automated multiple specimen system shown in
  • Fig. 2 for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention
  • Fig. 8 illustrates an example of a pipetter tip used with the pipetter assembly shown in Figs. 6 and 7 in the integrated and automated multiple specimen system shown in Fig. 2 for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention
  • Fig. 9 illustrates a perspective view of a tube rack with an identification system for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in
  • Fig. 10 illustrates a perspective of a portion of the tube rack identification station as shown in Fig. 9 for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention
  • Fig. 11 illustrates an exploded perspective view showing a portion of the tube rack identification station assembly as shown in Fig. 9 for use in the integrated and automated multiple specimen system as shown in Figs. 2 and 3 for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention
  • Fig. 12 illustrates a perspective view of a pipette tip holder station for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and
  • Fig. 13 illustrates a perspective view of a pipetter tip holder with tip exchange station for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention
  • Fig. 14 illustrates a perspective view of priming heater plates for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention
  • Fig. 15 illustrates an exploded perspective view of an extractor system for use in the integrated and automated multiple specimen system for the isolation, a plification and detection of targeted nucleic acid sequences as shown in Figs. 2 and
  • Fig. 16 illustrates a perspective view of an assay reader stage for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention
  • Fig. 17 illustrates a perspective view of multiple position microtiter plate with wells for use in the assay ready of Fig. 16 in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention
  • Fig. 18 illustrates a perspective view of a multiple position microtiter plate as shown in Fig. 17;
  • Fig. 19 illustrates a perspective view of a portion of a microtiter well assembly as shown in Fig. 17;
  • Fig. 20 illustrates a perspective view of a plate sealer gripper tool for use in applying a sealing plate to the microtiter plate shown in Fig. 17 in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention.
  • Fig. 21 is a flowchart illustrating an example of steps of a method for operating the fully integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Fig. 2.
  • Fig. 1 illustrates a known method for manually preparing multiple specimen samples for the isolation, amplification and detection of targeted nucleic acid sequences which employs the BDProbeTecTM ET System that provides sensitive and specific detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) from clinical samples.
  • CT Chlamydia trachomatis
  • GC Neisseria gonorrhoeae
  • SDA Strand Displacement Amplification
  • samples are processed, lysed and manually pipetted from sample tubes to priming and amplification wells.
  • the system 200 illustrated in Fig.
  • the system 200 achieves reliable automation through the use of an industrial grade robotic arm 524 (see Figs. 3 and 5) which in this embodiment is a selectively compliant articulated robot arm (SCARA) that has a mean time between failure of 20,000 hours or 10 years of single shift use.
  • SCARA selectively compliant articulated robot arm
  • the pipetter assembly 522 is comprised of pipetter tips 528, as well as other components, which have a range of 20-1100 ⁇ L ⁇ 10% with > 1 year Preventative Maintenance Interval (PMI) or 1,000,000 cycles. Unlike other clinical instrumentation, the system 200 utilizes no perishable tubing for fluid movement. [0052] Procedure for Setting up the system 200
  • Fig. 3 illustrates a block diagram of a fully integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention.
  • the automated multiple specimen preparation system (system) 200 shown in Fig. 3 is comprised of an assay reader stage 502, plate seals 504, LCD touch screen 506, keyboard drawer 508, tube rack with identification system (tube ID rack) 510, pipette tip holder 512, input sample tube rack 514, extractor 516, 5 position tip rack reagent trough 518, waster port 520, robotic arm 524 and priming heater plates 526 (with vacuum tool).
  • extraction device 516 there exists more than one type of extraction device that can be used in accordance with the embodiments of the invention, more fully described below, as one skilled in the art can appreciate.
  • One such extraction device is extractor 516, which is described in detail in U.S. Patent Application Serial No. 09/573,540 "System and Method for Manipulating Magnetic Particles in Fluid Samples to Collect DNA or RNA from a Sample," T. Hansen et al., and U.S. Patent Application Serial No. 09/858,889 “System and Method for Manipulating Magnetic Particles in Fluid Samples to Collect DNA or RNA from a Sample," T. Hansen et al. Additionally, the pipetter assembly 522 is more fully described in U.S. Patent Application Serial No.
  • Fig. 4 illustrates a conceptual block diagram at the system 200, showing the main components of the system 200, and how samples are processed .
  • the dashed lines illustrate when robotic arm 524 is used to move sample material (with pipette tips 528) and other devices.
  • Fig. 4 includes a micro-controller (which can also be a "local” or “remote” PC) 564, or any other suitable controller.
  • a micro-controller which can also be a "local” or "remote” PC
  • operation of system 200 is controlled by a program which can be stored and operated locally and/or remotely. A detailed description of such devices and method of operation is excluded, as one skilled in the relevant and related arts can understand its operation.
  • a controller can include a display 560, printer 562, micro-controller 564, with mouse 568 and/or keypad 566, memory 558, I/O interface 570 and data/control bus 556.
  • the automated system 200 makes use of a robotic arm
  • Components include an input sample tube rack 510 with sample tacking mechanism (Figs. 9-11), an extractor subsystem used to isolate and concentrate nucleic acid from input sample (Fig. 15), heated priming and amplification stations (Fig. 14) used for the amplification of isolated nucleic acid and readers which monitor amplification of specific target analytes (Fig. 16). All steps of the process are fully automated by the use of an industrial grade robotic arm (Fig. 5) with an attached pipetting apparatus (Figs. 6-8, 12 and 13) capable of transferring fluids using disposable pipette tips 528 to prevent cross contamination of liquid samples.
  • the pipetting assembly 522 makes use of pressure transducers to detect the presence of filtered pipette tips 528 on the nozzle of the pipetter and to sense liquid levels in sample test tubes (Figs. 9-11).
  • a computer program that allows run-specific input to be entered via an integrated LCD touch screen monitor 506 controls all processing steps.
  • the system 200 is fully self-contained in an enclosure with sliding acrylic windows that protects the operator from the moving robotic arm 524 and prevents any aerosols that may be present in the liquid samples from escaping.
  • Replaceable containers, accessible from below the instrument are used to collect the contaminated pipette tips 528 and liquid waste.
  • SCARA robot has motions very much like a human body. These devices incorporate both a shoulder and elbow joint as well as a wrist axis and a vertical motion. SCARA robots were invented in Japan in the early 1960's and have been used extensively in many different industries since then.
  • SCARA robots are ideal for a variety of general purpose applications which require fast, repeatable, and articulate, point-to-point movements. Examples of their uses include palletizing & de-palletizing, loading and unloading, and assembly. Because of their unique "elbow" motions, SCARA robots are also ideal for applications which require constant acceleration through circular motions, such as dispensing and gasket-forming in-place. SCARA robot joints are all capable of rotation and can be thoroughly sealed and safeguarded, which is necessary should the robot be deployed in dusty or corrosive environments. SCARA robots are generally faster than cartesian robots and can perform multiple motions at their joints. Robotic ann 524, illustrated in Fig. 7, is an example of a SCARA-type robotic arm.
  • system 200 is not limited to the use of a SCARA, but rather can use any other suitable type of robotic device, such as an articulated robot, that will enable the system 200 to perform its intended functions.
  • SCARA SCARA
  • any other suitable type of robotic device such as an articulated robot
  • the following is a description of the method described in Fig. 21, in which reference is made to a specific use of one of the embodiments of the invention, which is the processing of a targeted nucleic acid.
  • the invention is not limited to this specific embodiment, nor to the processing of a targeted nucleic acid, but the invention has several different embodiments, and can instead be used for the processing of targeted or non-targeted nucleic acids and/or targeted or non-targeted proteins. Referring to Fig.
  • the method for operating the system 200 begins with step 102, in which the user first loads the disposable pipette tips 528, extractor tubes, liquid reagents, priming and amplification microwells and plate seals.
  • step 102 the user first loads the disposable pipette tips 528, extractor tubes, liquid reagents, priming and amplification microwells and plate seals.
  • an empty sample tube rack 510 is placed into the tube rack log in station.
  • the operator scans the tube rack bar 510 code via the handheld bar code wand and then scans each sample tube to be tested and places the tube into the tube rack 510.
  • a membrane keypad 554 mounted below the tube rack 510 is activated, communicating the location of the tube to the computer.
  • the operator continues to wand each tube and places it into the tube rack 510 until all tubes to be processed are loaded.
  • the computer has logged the tube rack 510 identity and the patient information and location of each tube loaded in the tube rack 510.
  • the tube rack 510 is then placed into the tube processing station 546.
  • a stationary bar code reader located below the tube rack 510 reads the tube rack 510 identification and relates the tube rack 510 identification to the database of patient information logged for that particular tube rack 510. This information is tracked to the final stage of the process when the patient results are printed.
  • the user closes the acrylic windows and initiates the run via the LCD touch screen 506.
  • robotic arm 524 picks-up pipette tips 528 and transfers fluid from each sample tube into a corresponding extraction tube 548.
  • the extraction tubes are pre-filled with magnetic particles and lysing reagents and covered with a foil film that the robotic arm 524 punctures when dispensing the fluid sample into the tube.
  • the robotic arm 524 mixes the sample to resuspend the extraction tube components. All mixing steps can be conducted, but not necessarily, under the influence of a degaussing field to facilitate particle dispersion.
  • the robotic arm 524 disposes of the pipette tips 528 and acquires new pipette tips 528 after each sample transfer. This process continues until all of the samples have been transferred into their corresponding extractor tubes.
  • the sample may be loaded directly into the extractor device.
  • the sample is in a container which may be pre-filled with the necessary reagents and/or material for extraction.
  • step 106 heaters 572 within the extractor subsystem 516 heat the sample to a suitable temperature that causes the release of nucleic acid from the microorganisms contained in the biological sample.
  • the heaters 572 are then disabled allowing the lysed samples to cool.
  • the nucleic acid may be released from the microorganisms contained in the biological sample by chemical means. Means of chemical extraction are described in "Chemical Pre-treatment of Plasma for Nucleic Acid Amplification Assays," U.S. Serial No. 10/359,180 and "Pretreatment Method for Extraction of Nucleic Acid from Biological Samples and Kits Therefor", U.S. Serial No. 10/359,179.
  • the robotic arm 524 picks up new pipette tips 528, aspirates binding reagent, dispenses and mixes binding reagent into the first group of extraction tubes using a different pipette tip 528 for each sample. This process non-specifically binds the nucleic acid onto the magnetic particles.
  • magnets 550 within the extractor subsystem 516 are automatically moved into position to collect the magnetic particles to the sides of the tubes. The robotic arm 524, using the same pipette tips 528, aspirates the waste liquid from each extractor tube leaving the magnetic particles with attached total nucleic acid locked to the side of the tube (step 111).
  • step 112 robotic arm 524 picks up new pipette tips 528, aspirates the wash reagent, dispenses, and then mixes the wash reagent with the magnetic particles and bound nucleic acid material.
  • step 114 the magnets 550 are then moved into position to lock the particles to the sides of the tube and the robotic arm 524, using the same pipette tips 528 removes the liquid waste wash reagent (step 115), leaving the washed, nucleic acid bound particles locked to the side of the tubes.
  • the magnets 550 are then moved to the position below the tubes.
  • elution buffer is aspirated into pipette tips 528.
  • the elution buffer is then dispensed into, and mixed with, the magnetic particles, thereby releasing the total nucleic acid from the magnetic particles (step 117).
  • a volume of elution buffer which is lower relative to the input sample volume can be utilized to effectively concentrate the nucleic acids.
  • the magnets 550 are moved up to the lock-down position and the robotic arm 524 pipettes the eluted sample containing concentrated nucleic acid into the priming wells (step 119). Further details of the non-specific nucleic acid binding processes are set forth in U.S. Patent Applications serial no. 09/858,889, referenced above.
  • the priming heater plates 526 are enabled, elevating the temperature of the priming wells to a suitable heat spike temperature, which disrupts non-specifically hybridized oligonucleotides (step 120).
  • robotic arm 524 then aspirates the appropriate volume of sample from the priming wells and dispenses it into the amplification/reader wells.
  • the robotic arm 524 picks-up the plate seal gripper tool 544, picks-up a plate seal 504 and places the plate seal 504 on the amplification plate 530.
  • the sealed amplification plate 530 is transferred into the assay reader chamber 502, which maintains as series of temperatures required for amplification of target nucleic acids (step 122).
  • step 124 The assay reader chamber 502 moves the sealed amplification plate 530 over the read heads 552 to detect nucleic acid amplification products.
  • the assay reader chamber 502 determines the test result, and provides the data via a printout. The locations of the test results match the location of the original sample tubes. Two sets of priming plates and two sets of amplification/reader plates are provided to support one or two tests per sample. Further details of the assay reader are set forth in U.S. Patent No. 6,043,880, referenced above.
  • Alternative methods of sample processing include automating nucleic acid extraction with the use of silica membranes.
  • lysed sample fluids mixed with binding reagents are pipetted into an open vessel with a silica membrane suspended in the center.
  • a vacuum is employed to draw the sample through the membrane trapping the nucleic acid in the membrane and allowing the remaining waste fluid to be discarded.
  • Reagents are then used to release the nucleic acid from the membrane.
  • Issues with automating this approach require the assembly and disassembly of a vacuum chamber. Using automation to achieve this complex task can be problematic especially since all parts must be airtight. Additionally, unused sections of the device must be blocked (usually manually with tape) to allow an even vacuum to be achieved over the active portion of the device.
  • Efficient capture of total nucleic acids is particularly challenging in the more viscous, high-protein samples such as plasma.
  • protocols utilizing the system 200, which allow efficient capture of nucleic acids in viscous samples such as plasma and expressed vaginal swabs.

Abstract

A system and method for preparing and testing of targeted nucleic acids is presented. The system integrates a pipetter (522), extractor (516), assay reader (502), and other components, including a selectively compliant articulated robot arm (SCARA) (524). This synergistic integration of previously separate diagnostic tools creates a system and method whereby a minimum of human intervention is required. The resulting system provides a substantially more accurate and precise method of isolating, amplifying and detecting targeted nucleic acids for diagnosing diseases.

Description

AUTOMATED SYSTEM FOR ISOLATING,
AMPLIFYING AND DETECTING A TARGET
NUCLEIC ACID SEQUENCE
Field of the Invention;
[0001] The invention is related to the detection of nucleic acids. More particularly, the invention is related to a system and method for the isolation, amplification and detection of targeted nucleic acids in a fully automated and integrated system that comprises a pipetter, extractor and an assay reader, as well as many other devices, to detect the targeted nucleic acids. -Related subject matter is disclosed in co-pending U.S. provisional patent application Serial No. 60/380,859, filed May 17, 2002, the entire contents of which are incorporated by reference. Related subject matter is disclosed in co-pending U.S. provisional patent application Serial No. 60/380,859, filed May 17, 2002, the entire contents of which are incorporated by reference.
Background of the Invention
[0002] None of the references described or referred to herein are admitted to be prior art to the claimed invention.
[0003] A variety of molecular biology methodologies, such as nucleic acid sequencing, direct detection of particular nucleic acids sequences by nucleic acid hybridization, and nucleic acid sequence amplification techniques, require that the nucleic acids (DNA or RNA) be separated from the remaining cellular components. This process generally includes the steps of collecting the cells in a sample tube and lysing the cells with heat and/or reagent(s) which causes the cells to burst and release the nucleic acids (DNA or RNA) into the solution in the tube. The tube is then placed in a centrifuge, and the sample is spun down so that the various components of the cells are separated into density layers within the tube. The layer of the nucleic acids can be removed from the sample by a pipette or any suitable instrument. The samples can then be washed and treated with appropriate reagents, such as fluorescein probes, so that the nucleic acids can be detected in an apparatus such as the BDProbeTec® ET system, manufactured by Becton Dickinson and Company and described in U.S. Patent No. 6,043,880 to Andrews et al., the entire contents of which is incorporated herein by reference.
[0004] Although the existing techniques for separating nucleic acids from cell samples may be generally suitable, such methods are typically time consuming and complex. When performed manually, the complexity and number of processing steps associated with a nucleic acid based assay also introduce opportunities for practitioner error, exposure to pathogens and cross contamination between assays. Furthermore, although the centrifuging process is generally effective in separating the nucleic acids from the other cell components, certain impurities having the same or similar density as the nucleic acids can also be collected in the nucleic acid layer, and must be removed from the cell sample with the nucleic acids.
[0005] A technique has recently been developed which is capable of more effectively separating nucleic acids from the remaining components of cells. This technique involves the use of paramagnetic particles, and is described in U.S. Patent No. 5,973,138 to Mathew P. Collis, the entire contents of which is incorporated herein by reference.
[0006] In this technique, paramagnetic or otherwise magnetic or magnetizable particles are placed in an acidic solution along with cell samples. When the cell samples are lysed to release the nucleic acids, the nucleic acids are reversibly bound to the particles. The particles can then be separated from the remainder of the solution by known techniques such as centrifugation, filtering or magnetic force. The particle to which the nucleic acids are bound can then be removed from the solution and placed in an appropriate buffer solution, which causes the nucleic acids to become unbound from the particles. The particles can then be separated from the nucleic acids by any of the techniques described above. [O007] Examples of systems and method for manipulating magnetic particles are described in U.S. Patent Nos. 3,988,240, 4,895,650, 4,936,687, 5,681,478, 5,804,067 and 5,567,326, in European Patent Application No. EP905520A1, and in published PCT Application WO 96/09550, the entire contents of each of said documents being incorporated herein by reference.
[O008] Techniques also exist for moving solutions between containers, such as test tubes, sample wells, and so on. In an automated pipetting technique, in order to properly control a pipetter device to draw fluid from a sample container such as a test tube, it is necessary to know the level of the sample fluid in the tube so the pipette can be lowered to the appropriate depth. It is also necessary to detect whether the pipette tip has been properly connected to the pipetter device. Prior methods to detect the level of a fluid in a container include the use of electrical conductivity detection. This method requires the use of electrically conductive pipette tips connected to a sensitive amplifier which detects small changes in the electrical capacitance of the pipette tip when it comes in contact with an ionic fluid. Pipette tip detection in this known system is achieved by touching the end of the conductive pipette tip to a grounded conductor. Drawbacks of this approach include the higher cost of conductive pipette tips, and that the method only works effectively with ionic fluids. In other words, if the fluid is non-conductive, it will not provide a suitable electrical path to complete the circuit between the conductors in the pipette tip.
[O009] A system and method for the measurement of the level of fluid in a pipette tube has been described in U.S. Patent No. 4,780,833, issued to Atalce, the contents of which are herein incorporated by reference. Atake's system and method involves applying suction to the liquid to be measured, maintaining liquid in a micro-pipette tube or tubes, and providing the tubes with a storage portion having a large inner diameter and a slender tubular portion with a smaller diameter. A pressure gauge is included for measuring potential head in the tube or tubes. Knowing the measured hydraulic head in the pipette tube and the specific gravity of the liquid, the amount of fluid contained in the pipette tube can be ascertained. [0010] Devices used in molecular biology methodologies can incorporate the pipette device mentioned above, with robotics, to provide precisely controlled movements to safely and carefully move sample biological fluids from one container to another. Typically, these robotic devices are capable of coupling to one or more of the aforementioned pipette tips, and employ an air pump or other suitable pressurization device to draw the sample biological fluid into the pipette tips. [0011] The advent of DNA probes, which can identify a specific bacteria by testing for the presence of a unique bacterial DNA sequence in the sample obtained from the patient, has greatly increased the speed and reliability of clinical diagnostic testing. A test for the tuberculosis mycobacterium, for example, can be completed within a matter of hours using DNA probe technology. This allows treatment to begin more quickly and avoids the need for long patient isolation times. The nucleic acid sequence separating technique and the pipetting technique described above can be used to prepare samples to be used in conjunction with DNA probe technology for diagnostic purposes.
[0012] In the use of DNA probes for clinical diagnostic purposes, a nucleic acid amplification reaction is usually carried out in order to multiply the target nucleic acid into many copies or amplicons. Examples of nucleic acid amplification reactions include strand displacement amplification (SDA), rolling circle amplification (RCA), self-sustained sequence replication (3SR), transcription-mediated amplification (TMA), nucleic acid-sequence-based amplification (NASBA), ligase chain reaction (LCR) and polymerase chain reaction (PCR). Methods of nucleic acid amplification are described in the literature. For example, PCR amplification, for instance, is described by Mullis et al. in U.S. Pat. Nos. 4,683,195, 4,683,202 and 4,800,159, and in Methods in Enzymology, 155:335-350 (1987). Examples of SDA can be found in Walker, PCR Methods and Applications, 3:25-30 (1993), Walker et al. in Nucleic Acids Res., 20:1691-1996 (1992) and Proc. Natl. Acad. Sci., 89:392-396 (1991). LCR is described in U.S. Pat. Nos. 5,427,930 and 5,686,272. And different TAA formats are provided in publications such as Burg et al. in U.S. Pat. No. 5,437,990; Kacian et al. in U.S. Pat. Nos. 5,399,491 and 5,554,516; and Gingeras et al. in International Application No. PCT/US87/01966 and International Publication No. WO 88/01302, and International Application No. PCT/US88/02108 and International Publication No. WO 88/10315.
[0013] Detection of the nucleic acid amplicons can be carried out in several ways, all involving hybridization (binding) between the target DNA and specific probes. Many common DNA probe detection methods involve the use of fluorescein dyes. One detection method is fluorescence energy transfer. In this method, a detector probe is labeled both with a fluorescein dye that emits light when excited by an outside source, and with a quencher which suppresses the emission of light from the fluorescein dye in its native state. When DNA amplicons are present, the fluorescein- labeled probe binds to the amplicons, is extended, and allows fluorescence emission to occur. The increase of fluorescence is taken as an indication that the disease-causing bacterium is present in the patient sample.
[0014] Other detection methods will be apparent to those skilled in the art. For example, a single fluorescent label may be employed on the reporter moiety with detection of a change in fluorescence polarization in the presence of the complement of the reporter moiety (see US Patent No. 5,593,867). Non-fluorescent labels are also useful. For example, the reporter moiety may be labeled with a lipophilic dye and contain a restriction site which is cleaved in the presence of the complement of the reporter moiety (see US Patent No. 5,550,025). Alternatively, the reporter probe may be radiolabeled and the products resulting from synthesis of the complement of the reporter moiety may be resolved by electrophoresis and visualized by autoradiography. Immuno logical labels may also be employed. A reporter probe labeled with a hapten can be detected after synthesis of the complement of the reporter moiety by first removing unreacted reporter probe (for example by adapter-specific capture on a solid phase) and then detecting the hapten label on the reacted reporter probe using standard chemiluminescent or colorimetric ELISAs. A biotin label may be substituted for the hapten and detected using methods known in the art. Chemiluminescent compounds which include acridiuium esters which can be used in a hybridization protection assay (HP A) and then detected with a luminometer (see US Patent Nos 4,950,613 and 4,946,958).
[0015] One broad category of detection devices that can be used in the various embodiments of the invention (more fully described in detail below), are optical readers and scanners. Several types of optical readers or scanners exist which are capable of exciting fluid samples with light, and then detecting any light that is generated by the fluid samples in response to the excitation. For example, an X-Y plate scanning apparatus, such as the CytoFluor Series 4000 made by PerSeptive Biosystems, is capable of scanning a plurality of fluid samples stored in an array or plate of microwells. The apparatus includes a scanning head for emitting light toward a particular sample, and for detecting light generated from that sample. The apparatus includes first and second optical cables each having first and second ends. The first ends of the optical cables are integrated to form a single Y-shaped "bifurcated" cable. The scam ing head includes this end of the bifurcated optical cable. The second end of the first optical cable of the bifurcated cable is configured to receive light from a light emitting device, such as a lamp, and the second end of the second cable of the bifurcated cable is configured to transmit light to a detector, such as a photomultipHer tube.
[0016] During operation, the optical head is positioned so that the integrated end of the bifurcated optical fiber is at a suitable position with respect to one of the microwells. The light emitting device is activated to transmit light through the first optical cable of the bifurcated optical cable such that the light is emitted out of the integrated end of the bifurcated optical cable toward the sample well. If fluid sample fluoresces in response to the emitted light, the light produced by the fluorescence is received by the integrated end of the optical fiber and is transmitted through the second optical fiber to the optical detector. The detected light is converted by the optical detector into an electrical signal, the magnitude of which is indicative of the intensity of the detected light. The electrical signal is processed by a computer to determine whether the target DNA is present or absent in the fluid sample based on the magnitude of the electrical signal.
[0017] Another existing type of apparatus is described in U.S. Patent No. 5,473,437, to Blumenfeld et al. This apparatus includes a tray having openings for receiving bottles of fluid samples. The tray includes a plurality of optical fibers which each have an end that terminates at a respective opening in the tray. The tray is connected to a wheel, and rotates in conjunction with the rotation of the wheel. The other ends of the optical fibers are disposed circumferentially in succession about the wheel, and a light emitting device is configured to emit light toward the wheel so that as the wheel rotates, the ends of the optical fibers sequentially receive the light being emitted by the light emitting device. That is, when the wheel rotates to a first position, a fiber extending from the wheel to one of the openings becomes aligned with the optical axis of the light emitting device and thus, the emitted light will enter that fiber and be transmitted to the opening. The apparatus further include a light detector having an optical axis aligned with the optical axis of the emitted light. Accordingly, if the sample in the bottle housed in the opening fluoresces due to the excitation light, the light emitted from the sample will transmit through the optical fiber and be detected by the detector. The wheel then continues to rotate to positions where the ends of the other optical fibers become aligned with the optical axis of the light emitter and light detector, and the light emission and detection process is repeated to sample the fluid samples in the bottles housed in the openings associated with those fibers.
[0018] Another type of optical testing apparatus is described in U.S. Patent No. 5,518,923, to Bemdt et al. That apparatus includes a plurality of light emitter/light detector devices for testing a plurality of fluid samples. The fluid samples are contained in jars which are placed in the openings of a disk-shaped tray. The plurality of the light emitter/detector devices are disposed in the radial direction of the tray. Hence, as the tray rotates, the samples in each circular row will pass by their respective light emitter/detector device, which will transmit light into the sample and detect any light that is generated by the sample in response to the emitted light. In theory, this apparatus is capable of testing more than one sample at any given time. However, in order to achieve this multiple sample testing ability, the system must employ a plurality of light detectors and a plurality of light emitters. These additional components greatly increase the cost of the system. For example, photomultiplier tubes, which are generally quite expensive, are often used as light detector units in devices of this type. Hence, the cost of the unit is generally increased if more than one photomultiplier tube is used. However, it is desirable to use as few photomultiplier tubes as possible to maintain a competitive price for the apparatus. However, devices which employ a single detector (e.g., photomultiplier tube) are incapable of testing a plurality of samples without some type of mechanical motion for each test.
[0019] A detector apparatus is also described in U.S. Patent No. 4,343,991, to
Fujiwara et al. This apparatus employs a single light detector and a plurality of light emitting devices to read a sample on a sample carrier, which is a substantially transparent medium. In this apparatus, the plurality of light emitting devices transmit light through corresponding optical fibers. The light emitted by the optical fibers passes through the. carrier and is received by corresponding optical fibers on the opposite side of the carrier. The receiving fibers terminate at a single light detector and the light emitters are operated to emit light at different times. Hence, light from only one of the emitters passes through the carrier at any given time and is detected by the detector, which outputs a signal proportional to the intensity of the detected light. Therefore, a single detector can be used to detect light from a plurality of light emitting devices. When the light passes through a portion of the carrier that includes a sample, the intensity of the light is decreased because some of the light is absorbed by the sample. The amount by which the light intensity is reduced is proportional to the concentration of the sample material in the sample. Because the signal output by the detector is proportional to the intensity of the detected light, the sample concentration can thus be determined based on the output signal. [O020] Although the nucleic acid separating techniques, the pipetting techniques, and the sensory techniques discussed above exist separately, what is lacking, is an integrated system that synergistically combines these and other tools to create an advanced, easy-to-operate system for the isolation, amplification and detection of targeted nucleic acids to diagnose diseases by manipulating fluid samples. Past approaches to automate sample processing were limited to automating portions of the process leaving the remaining tasks to be performed by a technician. For example, many earlier systems employ a manual centrifugation step that requires a technician to load sample tubes into and out of an external centrifuge. Other systems require a technician to transfer extraction products from a nucleic acid extraction instrument to an amplification and/or detection instrument.
[0021] Certain attempts have been made at providing limited automation to sample handling systems. For example, certain systems utilize cartesian robots for moving samples from one location to another. As known in the art, cartesian robots can move in X, Y and Z direction, are able to perform straight-line insertions and are easy to program. Cartesian robots have the most rigid robotic structure for a given length, since the axes can be supported at both ends. Due to their rigid structure, cartesian robots can manipulate relatively high loads. This enables them to be used for pick-and-place applications, machine tool loading, and stacking parts into bins. Cartesian robots can also be used for assembly operations and liquid dispensing systems. Examples of such uses occur in laboratory applications (genetic research), or any task that is high volume and repetitive.
[0022] One disadvantage of cartesian robots, however, is that they require a large area of space in which to operate, or, in other words, have a large footprint to workspace ratio. Another disadvantage is that cartesian robots have exposed mechanical elements which are difficult to seal from wet, corrosive or dusty environments, and are difficult to decontaminate. [0023] In addition, selectively compliant articulated robot arms (SCARA) robots have been used in the genome area to pick colonies and transfer them from a media plate to a sample plate.
[0024] Although the systems discussed above may be useful in certain capacities, it a need exists to have a fully automated system for processing a component of interest, wherein such processing includes isolating, amplifying and detecting, and the component of interest includes a specific or non specific nucleic acid sequence and/or protein. Significant advantages can be realized by automating the various process steps of an assay, including greatly reducing the risk of user-error, pathogen exposure, contamination, and spillage, while increasing efficiency. Automating steps of an assay will also reduce the amount of training required for practitioners and virtually eliminate sources of injury attributable to high- volume applications.
Summary of the Invention
[0025] It is therefore a general object of the invention to provide a novel processing system that will obviate or minimize problems of the type previously described.
[0026] In order to achieve this and other objects of the present invention, an automated system for processing a component of interest contained in a sample is provided comprising a sample rack, adapted for receiving at least one container containing the sample, an extraction device, adapted to extract said component of interest from the sample, a detection device, adapted to detect for the presence of said component of interest extracted by said extraction device, and a robot, adapted to automatically transfer the sample to the extraction device, and to automatically transfer said extracted component of interest from said extraction device to said detection device.
[0027] In accordance with an embodiment of the present invention, the centrifugation step discussed above is eliminated and instead accomplished with the use of a magnetic particle extractor subsystem. Utilization of non-specific nucleic acid capture provides advantages of lower reagent cost and improved robustness relative to more complex specific capture systems. The low cost of the non-specific capture particles (iron oxide) allows flexibility to increase the capture matrix and scale binding capacity without significantly impacting cost. Additionally, the system uses an industrial grade (SCARA) robotic arm that provides accurate, repeatable and reliable positioning of the pipetter as opposed to laboratory liquid handling robotic platforms that use less reliable robotic components.
Brief Description of the Drawings
[0028] The novel features and advantages of the present invention will best be understood by reference to the detailed description of the specific embodiments which follows, when read in conjunction with the accompanying drawings, in which:
[0029] Fig. 1 illustrates a known method for manually preparing multiple specimen samples for the isolation, amplification and detection of targeted nucleic acid sequences;
[0030] Fig. 2 illustrates a perspective view of an automated multiple specimen preparation system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention;
[0O31] Fig. 3 illustrates an internal view of the fully integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Fig. 2 in accordance with an embodiment of the invention;
[0032] Fig. 4 illustrates a system block diagram of the major components of a fully integrated and automated multiple specimen system as shown in Fig. 2 and more fully described in reference to Fig. 3 and related figures;
[0033] Fig. 5 illustrates a perspective view of a SCARA robotic arm used in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention; [0034] Figs. 6 and 7 illustrate different perspective views of a six channel pipetter assembly used in the integrated and automated multiple specimen system shown in
Fig. 2 for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention;
[0035] Fig. 8 illustrates an example of a pipetter tip used with the pipetter assembly shown in Figs. 6 and 7 in the integrated and automated multiple specimen system shown in Fig. 2 for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention;
[0036] Fig. 9 illustrates a perspective view of a tube rack with an identification system for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in
Figs. 2 and 3 in accordance with an embodiment of the invention;
[0037] Fig. 10 illustrates a perspective of a portion of the tube rack identification station as shown in Fig. 9 for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention;
[0038] Fig. 11 illustrates an exploded perspective view showing a portion of the tube rack identification station assembly as shown in Fig. 9 for use in the integrated and automated multiple specimen system as shown in Figs. 2 and 3 for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention;
[0039] Fig. 12 illustrates a perspective view of a pipette tip holder station for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and
3 in accordance with an embodiment of the invention;
[0040] Fig. 13 illustrates a perspective view of a pipetter tip holder with tip exchange station for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention; [O041] Fig. 14 illustrates a perspective view of priming heater plates for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention;
[O042] Fig. 15 illustrates an exploded perspective view of an extractor system for use in the integrated and automated multiple specimen system for the isolation, a plification and detection of targeted nucleic acid sequences as shown in Figs. 2 and
3 in accordance with an embodiment of the invention;
[O043] Fig. 16 illustrates a perspective view of an assay reader stage for use in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention;
[O044] Fig. 17 illustrates a perspective view of multiple position microtiter plate with wells for use in the assay ready of Fig. 16 in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention;
[O045] Fig. 18 illustrates a perspective view of a multiple position microtiter plate as shown in Fig. 17;
[O046] Fig. 19 illustrates a perspective view of a portion of a microtiter well assembly as shown in Fig. 17;
[O047] Fig. 20 illustrates a perspective view of a plate sealer gripper tool for use in applying a sealing plate to the microtiter plate shown in Fig. 17 in the integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Figs. 2 and 3 in accordance with an embodiment of the invention; and
[0048] Fig. 21 is a flowchart illustrating an example of steps of a method for operating the fully integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences as shown in Fig. 2.
Detailed Description of the Preferred Embodiment
[0049] The various features of the preferred embodiment will now be described with reference to the figures, in which like parts are identified with the same reference characters.
[0050] Fig. 1 illustrates a known method for manually preparing multiple specimen samples for the isolation, amplification and detection of targeted nucleic acid sequences which employs the BDProbeTec™ ET System that provides sensitive and specific detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) from clinical samples. The technology is based on homogeneous Strand Displacement Amplification (SDA) and detection of target DNA. Currently, samples are processed, lysed and manually pipetted from sample tubes to priming and amplification wells. The system 200, illustrated in Fig. 2 (and discussed in detail below) has been developed to minimize pipetting and reduce hands-on time associated with the BDProbeTec™ ET CT/GC assays by automating pipetting from sample tubes to extractor, isolating the component of interest and then transferring the component of interest to priming wells and from priming to amplification wells. [0051] As discussed in more detail below, the system 200 achieves reliable automation through the use of an industrial grade robotic arm 524 (see Figs. 3 and 5) which in this embodiment is a selectively compliant articulated robot arm (SCARA) that has a mean time between failure of 20,000 hours or 10 years of single shift use. The pipetter assembly 522 is comprised of pipetter tips 528, as well as other components, which have a range of 20-1100 μL ± 10% with > 1 year Preventative Maintenance Interval (PMI) or 1,000,000 cycles. Unlike other clinical instrumentation, the system 200 utilizes no perishable tubing for fluid movement. [0052] Procedure for Setting up the system 200
[0053] First, power is turned on in the system 200. Second, pipette tips are loaded on to the system 200. Third, the priming and amplification microwells are loaded onto the system 200. Then, in step four, samples are loaded onto an instrument deck. Sample parameters and assay type are chosen via a touch screen in step five, and in step 6 the system 200 is enabled to run the processing program. [0054] The system 200 minimizes hands-on pipetting while achieving the same CT/GC specimen results per shift as the BDProbeTec™ ET manual system. [0055] As will now he described, the system 200 shown in Fig. 2 can be used for the isolation, amplification and detection of components of interest in accordance with an embodiment of the invention. These components of interest can include the specific or non specific capture of nucleic acids and/or proteins. Fig. 3 illustrates a block diagram of a fully integrated and automated multiple specimen system for the isolation, amplification and detection of targeted nucleic acid sequences in accordance with an embodiment of the invention. The automated multiple specimen preparation system (system) 200 shown in Fig. 3, is comprised of an assay reader stage 502, plate seals 504, LCD touch screen 506, keyboard drawer 508, tube rack with identification system (tube ID rack) 510, pipette tip holder 512, input sample tube rack 514, extractor 516, 5 position tip rack reagent trough 518, waster port 520, robotic arm 524 and priming heater plates 526 (with vacuum tool).
[0056] There exists more than one type of extraction device that can be used in accordance with the embodiments of the invention, more fully described below, as one skilled in the art can appreciate. One such extraction device is extractor 516, which is described in detail in U.S. Patent Application Serial No. 09/573,540 "System and Method for Manipulating Magnetic Particles in Fluid Samples to Collect DNA or RNA from a Sample," T. Hansen et al., and U.S. Patent Application Serial No. 09/858,889 "System and Method for Manipulating Magnetic Particles in Fluid Samples to Collect DNA or RNA from a Sample," T. Hansen et al. Additionally, the pipetter assembly 522 is more fully described in U.S. Patent Application Serial No. 10/073,207 "A System and Method for Verifying the Integrity of the Condition and Operation of a Pipetter Device For Manipulating Fluid Samples," T. Hansen et al. [0057] There exists more than one type of detection device that can be used in accordance with the embodiments of the invention, more fully described below, as one skilled in the art can appreciate. One such detection device is the assay reader 502 more fully described in U.S. Patent No. 6,043,880 "Automated Optical Reader for Nucleic Acid Assays", J. Andrews et al. these and other types of detection devices were described briefly in the background of the invention. The contents of each of the above referenced U.S. patent applications and U.S. Patents are expressly incorporated herein by reference.
[0058] Fig. 4 illustrates a conceptual block diagram at the system 200, showing the main components of the system 200, and how samples are processed . The dashed lines illustrate when robotic arm 524 is used to move sample material (with pipette tips 528) and other devices. Fig. 4 includes a micro-controller (which can also be a "local" or "remote" PC) 564, or any other suitable controller. Throughout the following discussion, and especially in conjunction with the accompanying description of the method illustrated in Fig. 21, operation of system 200 is controlled by a program which can be stored and operated locally and/or remotely. A detailed description of such devices and method of operation is excluded, as one skilled in the relevant and related arts can understand its operation. Such a controller can include a display 560, printer 562, micro-controller 564, with mouse 568 and/or keypad 566, memory 558, I/O interface 570 and data/control bus 556.
[0059] As discussed above, the automated system 200 makes use of a robotic arm
524 to perform all the steps required to isolate and amplify nucleic acid from a fluid sample. Components include an input sample tube rack 510 with sample tacking mechanism (Figs. 9-11), an extractor subsystem used to isolate and concentrate nucleic acid from input sample (Fig. 15), heated priming and amplification stations (Fig. 14) used for the amplification of isolated nucleic acid and readers which monitor amplification of specific target analytes (Fig. 16). All steps of the process are fully automated by the use of an industrial grade robotic arm (Fig. 5) with an attached pipetting apparatus (Figs. 6-8, 12 and 13) capable of transferring fluids using disposable pipette tips 528 to prevent cross contamination of liquid samples. The pipetting assembly 522 makes use of pressure transducers to detect the presence of filtered pipette tips 528 on the nozzle of the pipetter and to sense liquid levels in sample test tubes (Figs. 9-11). A computer program that allows run-specific input to be entered via an integrated LCD touch screen monitor 506 controls all processing steps.
[0060] The system 200 is fully self-contained in an enclosure with sliding acrylic windows that protects the operator from the moving robotic arm 524 and prevents any aerosols that may be present in the liquid samples from escaping. Replaceable containers, accessible from below the instrument are used to collect the contaminated pipette tips 528 and liquid waste.
[0061] Operation of the system 200 employing the SCARA robotic arm 524 will now be discussed, as can be appreciated by one skilled in the art, a SCARA robot has motions very much like a human body. These devices incorporate both a shoulder and elbow joint as well as a wrist axis and a vertical motion. SCARA robots were invented in Japan in the early 1960's and have been used extensively in many different industries since then.
[0062] SCARA robots are ideal for a variety of general purpose applications which require fast, repeatable, and articulate, point-to-point movements. Examples of their uses include palletizing & de-palletizing, loading and unloading, and assembly. Because of their unique "elbow" motions, SCARA robots are also ideal for applications which require constant acceleration through circular motions, such as dispensing and gasket-forming in-place. SCARA robot joints are all capable of rotation and can be thoroughly sealed and safeguarded, which is necessary should the robot be deployed in dusty or corrosive environments. SCARA robots are generally faster than cartesian robots and can perform multiple motions at their joints. Robotic ann 524, illustrated in Fig. 7, is an example of a SCARA-type robotic arm. It should be also noted that the system 200 is not limited to the use of a SCARA, but rather can use any other suitable type of robotic device, such as an articulated robot, that will enable the system 200 to perform its intended functions. [0063] The following is a description of the method described in Fig. 21, in which reference is made to a specific use of one of the embodiments of the invention, which is the processing of a targeted nucleic acid. However, as has been described above, and as one skilled in the art can appreciate, the invention is not limited to this specific embodiment, nor to the processing of a targeted nucleic acid, but the invention has several different embodiments, and can instead be used for the processing of targeted or non-targeted nucleic acids and/or targeted or non-targeted proteins. Referring to Fig. 21, the method for operating the system 200, begins with step 102, in which the user first loads the disposable pipette tips 528, extractor tubes, liquid reagents, priming and amplification microwells and plate seals. Next, an empty sample tube rack 510 is placed into the tube rack log in station. The operator scans the tube rack bar 510 code via the handheld bar code wand and then scans each sample tube to be tested and places the tube into the tube rack 510. As each tube is placed into the tube rack 510, a membrane keypad 554 mounted below the tube rack 510 is activated, communicating the location of the tube to the computer. The operator continues to wand each tube and places it into the tube rack 510 until all tubes to be processed are loaded. At the end of this process the computer has logged the tube rack 510 identity and the patient information and location of each tube loaded in the tube rack 510. [0064] The tube rack 510 is then placed into the tube processing station 546. A stationary bar code reader located below the tube rack 510 reads the tube rack 510 identification and relates the tube rack 510 identification to the database of patient information logged for that particular tube rack 510. This information is tracked to the final stage of the process when the patient results are printed. Next the user closes the acrylic windows and initiates the run via the LCD touch screen 506. [0065] In step 104, robotic arm 524 picks-up pipette tips 528 and transfers fluid from each sample tube into a corresponding extraction tube 548. The extraction tubes are pre-filled with magnetic particles and lysing reagents and covered with a foil film that the robotic arm 524 punctures when dispensing the fluid sample into the tube. The robotic arm 524 mixes the sample to resuspend the extraction tube components. All mixing steps can be conducted, but not necessarily, under the influence of a degaussing field to facilitate particle dispersion. The robotic arm 524 disposes of the pipette tips 528 and acquires new pipette tips 528 after each sample transfer. This process continues until all of the samples have been transferred into their corresponding extractor tubes. Alternatively, the sample may be loaded directly into the extractor device. In this embodiment the sample is in a container which may be pre-filled with the necessary reagents and/or material for extraction. [0066] During the next step, step 106, heaters 572 within the extractor subsystem 516 heat the sample to a suitable temperature that causes the release of nucleic acid from the microorganisms contained in the biological sample. The heaters 572 are then disabled allowing the lysed samples to cool. Alternatively, instead of using heat, or in combination with heat, the nucleic acid may be released from the microorganisms contained in the biological sample by chemical means. Means of chemical extraction are described in "Chemical Pre-treatment of Plasma for Nucleic Acid Amplification Assays," U.S. Serial No. 10/359,180 and "Pretreatment Method for Extraction of Nucleic Acid from Biological Samples and Kits Therefor", U.S. Serial No. 10/359,179.
[0067] After cool down, the robotic arm 524, in step 108, picks up new pipette tips 528, aspirates binding reagent, dispenses and mixes binding reagent into the first group of extraction tubes using a different pipette tip 528 for each sample. This process non-specifically binds the nucleic acid onto the magnetic particles. Next, in step 110, magnets 550 within the extractor subsystem 516 are automatically moved into position to collect the magnetic particles to the sides of the tubes. The robotic arm 524, using the same pipette tips 528, aspirates the waste liquid from each extractor tube leaving the magnetic particles with attached total nucleic acid locked to the side of the tube (step 111). The magnets 550 are then moved to their original position below the tubes, thus releasing the particles from the sides of the tubes. [0068] In step 112 robotic arm 524 picks up new pipette tips 528, aspirates the wash reagent, dispenses, and then mixes the wash reagent with the magnetic particles and bound nucleic acid material. In step 114 the magnets 550 are then moved into position to lock the particles to the sides of the tube and the robotic arm 524, using the same pipette tips 528 removes the liquid waste wash reagent (step 115), leaving the washed, nucleic acid bound particles locked to the side of the tubes. The magnets 550 are then moved to the position below the tubes. In step 116 elution buffer is aspirated into pipette tips 528. The elution buffer is then dispensed into, and mixed with, the magnetic particles, thereby releasing the total nucleic acid from the magnetic particles (step 117). A volume of elution buffer which is lower relative to the input sample volume can be utilized to effectively concentrate the nucleic acids. In step 118 the magnets 550 are moved up to the lock-down position and the robotic arm 524 pipettes the eluted sample containing concentrated nucleic acid into the priming wells (step 119). Further details of the non-specific nucleic acid binding processes are set forth in U.S. Patent Applications serial no. 09/858,889, referenced above. [0069] After a 20 minute room temperature incubation period, the priming heater plates 526 are enabled, elevating the temperature of the priming wells to a suitable heat spike temperature, which disrupts non-specifically hybridized oligonucleotides (step 120). In step 121, robotic arm 524 then aspirates the appropriate volume of sample from the priming wells and dispenses it into the amplification/reader wells. After all of the samples have been transferred from the priming heater plate 526 to the amplification plate 530, the robotic arm 524 picks-up the plate seal gripper tool 544, picks-up a plate seal 504 and places the plate seal 504 on the amplification plate 530. The sealed amplification plate 530 is transferred into the assay reader chamber 502, which maintains as series of temperatures required for amplification of target nucleic acids (step 122).
[0070] In step 124, The assay reader chamber 502 moves the sealed amplification plate 530 over the read heads 552 to detect nucleic acid amplification products. The assay reader chamber 502 determines the test result, and provides the data via a printout. The locations of the test results match the location of the original sample tubes. Two sets of priming plates and two sets of amplification/reader plates are provided to support one or two tests per sample. Further details of the assay reader are set forth in U.S. Patent No. 6,043,880, referenced above.
[0071] Alternative methods of sample processing include automating nucleic acid extraction with the use of silica membranes. In this case, lysed sample fluids mixed with binding reagents are pipetted into an open vessel with a silica membrane suspended in the center. A vacuum is employed to draw the sample through the membrane trapping the nucleic acid in the membrane and allowing the remaining waste fluid to be discarded. Reagents are then used to release the nucleic acid from the membrane. Issues with automating this approach require the assembly and disassembly of a vacuum chamber. Using automation to achieve this complex task can be problematic especially since all parts must be airtight. Additionally, unused sections of the device must be blocked (usually manually with tape) to allow an even vacuum to be achieved over the active portion of the device. [0072] Efficient capture of total nucleic acids (including low copies of specific targets of interest) is particularly challenging in the more viscous, high-protein samples such as plasma.. Through optimization of the extraction process, we have developed protocols utilizing the system 200, which allow efficient capture of nucleic acids in viscous samples such as plasma and expressed vaginal swabs. Key advances included minimizing protein pre-coating of particles by introducing the particles after plasma treatment. This reduces competition for potential binding sites between protein and nucleic acids and reduces aggregation of particles due to protein-protein interactions. Minimization of particle aggregation, in turn, facilitates more efficient particle mixing. The implementation of a degaussing field during aspiration mixing also enhances mixing efficiency by minimizing particle aggregation due to residual particle magnetism. The combination of these advances allows efficient nucleic acid extraction from viscous, proteinaceous samples without the aid of chaotropic salts. [0073] The present invention has been described with reference to certain exemplary embodiments thereof. However, it will be readily apparent to those skilled in the art that it is possible to embody the invention in specific forms other than those of the exemplary embodiments described above. This may be done without departing from the spirit of the invention. The exemplary embodiments are merely illustrative and should not be considered restrictive in any way. The scope of the invention is defined by the appended claims and their equivalents, rather than by the preceding description.

Claims

What is claimed is:
1. An automated system for processing a component of interest contained in at least one sample, comprising: an extraction device, adapted to extract said component of interest from the sample; a detection device, adapted to detect for the presence of said component of interest extracted by said extraction device; and a robot, adapted to automatically transfer said extracted component of interest from said extraction device to said detection device, wherein, said robot includes a selectively compliant articulated robot arm (SCARA).
2. An automated system as claimed in claim 1, wherein: said component of interest includes a nucleic acid; said extraction device is adapted to extract said nucleic acid from the sample; said detection device is adapted to detect the presence of said extracted nucleic acid; and said robot is adapted to automatically transfer said extracted nucleic acid to said detection device.
3. An automated system as claimed in claim 1, wherein: said extracted component of interest includes a nucleic acid; and said detection device includes a device for amplifying said nucleic acid.
4. An automated system as claimed in claim 3, wherein: said amplifying device includes a heater.
5. An automated system as claimed in claim 1, wherein: said extraction device is adapted to perform non-specific capture of said component of interest to extract said component of interest from the sample.
6. An automated system as claimed in claim 5, wherein said component of interest is a nucleic acid.
7. An automated system as claimed in claim 5, wherein said component of interest is a protein.
8. An automated system as claimed in claim 1, wherein: said robot is further adapted to transfer fluid to and remove fluid from said extractor to assist said extractor in extracting said component of interest.
9. An automated system as claimed in claim 1 , wherein the extraction device and detection device are integrated as a single unit.
10. An automated system as claimed in claim 1, further comprising: a sample rack, adapted for receiving at least one container containing the sample; and
, said robot being adapted to automatically transfer the sample from the container to the extraction device.
11. An automated system for extracting nucleic acid from a sample, comprising: a selectively compliant articulated robot arm (SCARA); and an extractor adapted to extract the nucleic acid from the sample.
12. An automated system as claimed in claim 11„ wherein said SCARA is adapted to move the sample from a container to an extractor.
13. An automated system as claimed in claim 11, wherein: said SCARA is further adapted to move said extracted nucleic acid from said extractor to a detector which is adapted to detect for the presence of said nucleic acid.
14. An automated system for extracting a target nucleic acid from a sample, comprising: an extractor, adapted to perform non-specific capture of the target nucleic acid, to extract the nucleic acid from the sample without separating the target nucleic acid from non-target nucleic acid that may exist in the sample; an amplifier, adapted to amplify said extracted nucleic acid; and a robot, adapted to automatically convey said extracted nucleic acid to the amplifier.
15. An automated system as claimed in claim 14, wherein: said robot is further adapted to transfer the sample from a container to said extractor.
16. An automated system as claimed in claim 14, wherein: said robot is further adapted to transfer fluid to the extractor to assist the extractor in extracting the target nucleic acid.
17. A method for processing a component of interest contained in a sample, comprising: operating an extraction device to extract said component of interest from the sample; operating a detector to detect for the presence of said component of interest extracted by said extraction device; and automatically transferring said extracted component of interest from said extraction device to said detection device, wherein said automatically transferring includes operating a selectively compliant articulated robot arm (SCARA) to perform said transferring.
18. A method as claimed in claim 17, wherein: said component of interest includes a nucleic acid; said extraction device operating step extracts said nucleic acid from the sample; said detection device operating step detects the presence of said extracted nucleic acid; and said automatically transferring step transfers the sample to the extraction device, and automatically transfers said extracted nucleic acid to said detection device.
19. A method as claimed in claim 17, wherein: said extracted component of interest includes a nucleic acid; and said detection device operating step includes amplifying said nucleic acid.
20. A method as claimed in claim 19, wherein: said amplifying includes heating said nucleic acid.
21. A method as claimed in claim 17, wherein: said extraction device operating step performs non-specific capture of said component of interest to extract said component of interest from the sample.
22. The method as claimed in claim 21 , wherein said component of interest is a nucleic acid.
23. The method as claimed in claim 21 , wherein said component of interest is a protein.
24. A method as claimed in claim 17, further comprising: automatically transferring fluid to said extractor to assist said extractor in extracting said component of interest.
25. The method as claimed in claim 17, wherein the extraction device and detection device are integrated as a single unit.
26. The method as claimed in claim 17, further comprising: receiving at least one container containing the sample in a sample rack; and automatically transferring the sample from the container to the extraction device using said SCARA.
27. A method for automatically extracting nucleic acid from a sample, comprising: operating a selectively compliant articulated robot arm (SCARA); and extracting the nucleic acid from the sample with an extractor.
28. The method as claimed in claim 27, wherein the step of operating said SCARA comprises: moving the sample from a container to the extractor.
29. A method as claimed in claim 27, further comprising: operating said SCARA to move said extracted nucleic acid from said extractor to a detector which is adapted to detect for the presence of said nucleic acid.
30. A method for automatically extracting a target nucleic acid from a sample, comprising: operating an extractor to perform non-specific capture on the target nucleic acid to extract the nucleic acid from the sample without separating the target nucleic acid from non-target nucleic acid that may exist in the sample; operating an amplifier to amplify said extracted nucleic acid; and automatically transferring said extracted nucleic acid from said extractor to the amplifier.
31. A method as claimed in claim 30, further comprising: automatically transferring the sample from a container to said extractor.
32. A method as claimed in claim 30, further comprising: automatically transfer fluid to the extractor to assist the extractor in extracting the target nucleic acid.
33. An automated process for isolating and amplifying a target nucleic acid sequence that may be present in a sample, said process comprising: automatically separating the target sequence from the fluid sample at a separation station by performing non-specific binding on the target sequence without the need to separate the target sequence from any non-target sequence that may exist in the sample; and automatically transporting the separated target sequence from the separation station to an amplifying incubation station.
PCT/US2003/015602 2002-05-17 2003-05-19 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence WO2003097808A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ES03728991.5T ES2594333T3 (en) 2002-05-17 2003-05-19 Automated system to isolate, amplify and detect a white nucleic acid sequence
JP2004506467A JP4532264B2 (en) 2002-05-17 2003-05-19 Automatic system, automatic processing method, and automatic nucleic acid extraction method
EP03728991.5A EP1506413B1 (en) 2002-05-17 2003-05-19 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence
AU2003233555A AU2003233555B2 (en) 2002-05-17 2003-05-19 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence
MXPA04011083A MXPA04011083A (en) 2002-05-17 2003-05-19 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence.
BRPI0310060A BRPI0310060B8 (en) 2002-05-17 2003-05-19 automated system for isolating, amplifying and detecting a target nucleic acid sequence or protein
KR10-2004-7018515A KR20050008720A (en) 2002-05-17 2003-05-19 Automated system for isolating, amplifying and detecting a target nucleic acid sequence
CA2483694A CA2483694C (en) 2002-05-17 2003-05-19 Automated system for isolating, amplifying and detecting a target nucleic acid sequence
NO20045307A NO20045307L (en) 2002-05-17 2004-12-03 Automated system for isolating, amplifying and detecting a malnucleic acid sequence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38085902P 2002-05-17 2002-05-17
US60/380,859 2002-05-17

Publications (3)

Publication Number Publication Date
WO2003097808A2 WO2003097808A2 (en) 2003-11-27
WO2003097808A9 true WO2003097808A9 (en) 2004-02-19
WO2003097808A3 WO2003097808A3 (en) 2004-07-15

Family

ID=29550028

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/015602 WO2003097808A2 (en) 2002-05-17 2003-05-19 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence

Country Status (14)

Country Link
US (4) US20040029260A1 (en)
EP (1) EP1506413B1 (en)
JP (1) JP4532264B2 (en)
KR (1) KR20050008720A (en)
CN (2) CN103399162B (en)
AU (1) AU2003233555B2 (en)
BR (1) BRPI0310060B8 (en)
CA (1) CA2483694C (en)
ES (1) ES2594333T3 (en)
MX (1) MXPA04011083A (en)
NO (1) NO20045307L (en)
RU (1) RU2004137103A (en)
WO (1) WO2003097808A2 (en)
ZA (1) ZA200409089B (en)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048734A (en) 1995-09-15 2000-04-11 The Regents Of The University Of Michigan Thermal microvalves in a fluid flow method
DE10011555T1 (en) * 1998-05-01 2012-02-02 Gen-Probe Inc. Automatic diagnostic analyzer and method
US6692700B2 (en) 2001-02-14 2004-02-17 Handylab, Inc. Heat-reduction methods and systems related to microfluidic devices
US6852287B2 (en) 2001-09-12 2005-02-08 Handylab, Inc. Microfluidic devices having a reduced number of input and output connections
US7829025B2 (en) * 2001-03-28 2010-11-09 Venture Lending & Leasing Iv, Inc. Systems and methods for thermal actuation of microfluidic devices
US7323140B2 (en) 2001-03-28 2008-01-29 Handylab, Inc. Moving microdroplets in a microfluidic device
US8895311B1 (en) 2001-03-28 2014-11-25 Handylab, Inc. Methods and systems for control of general purpose microfluidic devices
US7010391B2 (en) 2001-03-28 2006-03-07 Handylab, Inc. Methods and systems for control of microfluidic devices
US20040157219A1 (en) * 2003-02-06 2004-08-12 Jianrong Lou Chemical treatment of biological samples for nucleic acid extraction and kits therefor
US7601491B2 (en) * 2003-02-06 2009-10-13 Becton, Dickinson And Company Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
EP1654066B1 (en) 2003-07-31 2014-11-12 Handylab, Inc. Processing particle-containing samples
AU2005241080B2 (en) * 2004-05-03 2011-08-11 Handylab, Inc. Processing polynucleotide-containing samples
US8852862B2 (en) 2004-05-03 2014-10-07 Handylab, Inc. Method for processing polynucleotide-containing samples
JP4143046B2 (en) * 2004-06-02 2008-09-03 株式会社東芝 Nucleic acid detection substrate and nucleic acid detection method using the apparatus
JP2008511816A (en) * 2004-08-03 2008-04-17 ベクトン・ディキンソン・アンド・カンパニー Use of magnetic materials to separate samples
WO2006017428A2 (en) * 2004-08-03 2006-02-16 Becton, Dickinson And Company Use of magnetic material to direct isolation of compounds and fractionation of multipart samples
US8615368B2 (en) * 2005-03-10 2013-12-24 Gen-Probe Incorporated Method for determining the amount of an analyte in a sample
JP4328788B2 (en) * 2005-10-04 2009-09-09 キヤノン株式会社 Nucleic acid sample testing equipment
JP2009511059A (en) * 2005-10-11 2009-03-19 ハンディーラブ インコーポレイテッド Polynucleotide sample preparation device
JP5254040B2 (en) 2006-01-18 2013-08-07 アルゴス セラピューティクス,インコーポレイティド System and method for processing samples in a closed container and associated apparatus
JP4548359B2 (en) * 2006-02-20 2010-09-22 株式会社島津製作所 Reaction kit processing equipment
US10900066B2 (en) 2006-03-24 2021-01-26 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US7998708B2 (en) 2006-03-24 2011-08-16 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
WO2007112114A2 (en) 2006-03-24 2007-10-04 Handylab, Inc. Integrated system for processing microfluidic samples, and method of using same
US8883490B2 (en) 2006-03-24 2014-11-11 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US11806718B2 (en) 2006-03-24 2023-11-07 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
DK2021807T3 (en) * 2006-04-24 2013-09-23 Protedyne Corp Robot system with autonomous tools
WO2008061165A2 (en) * 2006-11-14 2008-05-22 Handylab, Inc. Microfluidic cartridge and method of making same
CA2692186C (en) * 2007-06-29 2019-03-12 Becton, Dickinson And Company Methods for extraction and purification of components of biological samples
US8324372B2 (en) 2007-07-13 2012-12-04 Handylab, Inc. Polynucleotide capture materials, and methods of using same
US8182763B2 (en) 2007-07-13 2012-05-22 Handylab, Inc. Rack for sample tubes and reagent holders
US8287820B2 (en) 2007-07-13 2012-10-16 Handylab, Inc. Automated pipetting apparatus having a combined liquid pump and pipette head system
US8105783B2 (en) 2007-07-13 2012-01-31 Handylab, Inc. Microfluidic cartridge
US9186677B2 (en) 2007-07-13 2015-11-17 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US8133671B2 (en) 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US9618139B2 (en) 2007-07-13 2017-04-11 Handylab, Inc. Integrated heater and magnetic separator
NZ584963A (en) 2007-10-02 2012-11-30 Theranos Inc Modular Point-of-care devices as addressible assay units with tips of assay units having interior to immobilize reagents by capillary action
US20100009351A1 (en) * 2008-07-11 2010-01-14 Handylab, Inc. Polynucleotide Capture Materials, and Method of Using Same
USD787087S1 (en) 2008-07-14 2017-05-16 Handylab, Inc. Housing
JP5623888B2 (en) 2009-12-10 2014-11-12 エフ.ホフマン−ラ ロシュアーゲーF.Hoffmann−La Roche Aktiengesellschaft Method for separating and detecting analytes
US20120058900A1 (en) * 2010-03-04 2012-03-08 Roche Molecular Systems, Inc. Hardware architecture of analyzers
CN103589627B (en) 2010-07-23 2015-11-18 贝克曼考尔特公司 For carrying out heat circulator module and the system of PCR in real time in PCR reaction vessel
EP2666008B1 (en) 2011-01-21 2021-08-11 Labrador Diagnostics LLC Systems and methods for sample use maximization
WO2012142516A1 (en) 2011-04-15 2012-10-18 Becton, Dickinson And Company Scanning real-time microfluidic thermo-cycler and methods for synchronized thermocycling and scanning optical detection
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
USD692162S1 (en) 2011-09-30 2013-10-22 Becton, Dickinson And Company Single piece reagent holder
AU2012315595B2 (en) 2011-09-30 2015-10-22 Becton, Dickinson And Company Unitized reagent strip
CN104040238B (en) 2011-11-04 2017-06-27 汉迪拉布公司 Polynucleotides sample preparation apparatus
ES2844324T3 (en) 2011-11-07 2021-07-21 Beckman Coulter Inc Robotic arm
CN104040357B (en) 2011-11-07 2016-11-23 贝克曼考尔特公司 Halver system and workflow
EP2776844B1 (en) 2011-11-07 2020-09-30 Beckman Coulter, Inc. Specimen container detection
WO2013070748A1 (en) 2011-11-07 2013-05-16 Beckman Coulter, Inc. Magnetic damping for specimen transport system
CN104105969B (en) 2011-11-07 2016-10-12 贝克曼考尔特公司 Centrifuge system and workflow
US9910054B2 (en) 2011-11-07 2018-03-06 Beckman Coulter, Inc. System and method for processing samples
BR112014018995B1 (en) 2012-02-03 2021-01-19 Becton, Dickson And Company systems to perform automated testing
RU2627383C2 (en) 2012-04-13 2017-08-08 Бектон, Дикинсон Энд Компани Additional research of samples with application of residual materials from previous test
AU2013202808B2 (en) 2012-07-31 2014-11-13 Gen-Probe Incorporated System and method for performing multiplex thermal melt analysis
MX2012010986A (en) * 2012-09-24 2014-03-24 Diana Elizabeth Calva Mendez Scalable pipette equipment of (nmx)-channels.
AU2013202805B2 (en) 2013-03-14 2015-07-16 Gen-Probe Incorporated System and method for extending the capabilities of a diagnostic analyzer
US20160319329A1 (en) * 2013-09-12 2016-11-03 Siemens Healthcare Diagnostics Inc. Dynamic assay selection and sample preparation apparatus and methods and machine-readable mediums thereof
WO2015192331A1 (en) * 2014-06-17 2015-12-23 深圳迈瑞生物医疗电子股份有限公司 Nucleic acid extraction apparatus and method of operation thereof
JP6681384B2 (en) 2014-07-30 2020-04-15 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Automated system for processing particles
EP3314269A4 (en) 2015-06-26 2019-01-23 Abbott Laboratories Reaction vessel exchanger device for a diagnostic analyzer
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
US11112418B1 (en) * 2016-07-29 2021-09-07 Labrador Diagnostics Llc Systems and methods for multi-analysis
JP6474369B2 (en) * 2016-08-29 2019-02-27 ファナック株式会社 Work transfer system and work transfer method
KR102256775B1 (en) * 2016-09-29 2021-05-27 (주)바이오니아 Apparatus of treating biological sample
US10427162B2 (en) 2016-12-21 2019-10-01 Quandx Inc. Systems and methods for molecular diagnostics
WO2018144814A1 (en) 2017-02-03 2018-08-09 Infinitesimal Llc Electroporation system with micromanipulator and probe
CN108410729B (en) * 2017-02-10 2021-10-26 Scl生物科技有限公司 Primary cell extraction equipment and use method thereof
US10473591B2 (en) * 2017-05-01 2019-11-12 Wyatt Technology Corporation High throughput method and apparatus for measuring multiple optical properties of a liquid sample
RS63202B1 (en) * 2017-06-30 2022-06-30 Inscripta Inc Automated cell processing methods, modules, instruments, and systems
EP4286055A3 (en) * 2017-07-10 2024-02-28 Gen-Probe Incorporated Analytical systems and methods for nucleic acid amplification using sample assigning parameters
WO2019014306A2 (en) * 2017-07-13 2019-01-17 Argos Therapeutics, Inc. Automated processing systems, apparatus, methods and related devices
JP2021508250A (en) * 2017-10-11 2021-03-04 シャンハイ・レンドゥ・バイオテクノロジー・カンパニー・リミテッドShanghai Rendu Biotechnology Co., Ltd. Automatic nucleic acid sample preparation, detection and analysis system
WO2019182903A1 (en) * 2018-03-20 2019-09-26 Nugen Technologies, Inc. Methods for linear sample processing
CN109628441A (en) * 2018-12-07 2019-04-16 山东森芃生物科技有限公司 A kind of full-automatic nucleic acid purifier
CN110437970A (en) * 2019-05-15 2019-11-12 湖北微伞医疗科技有限公司 Intestinal flora nucleic acid extraction system
US20220333180A1 (en) * 2019-09-10 2022-10-20 Jiaxing Accunome Biotechnology Co., Ltd. Instrument and method for extracting and detecting nucleic acids
CN111426666A (en) * 2020-02-27 2020-07-17 中国科学院上海技术物理研究所 High-throughput automatic detector for simultaneously detecting multiple kinds of viruses
US11255762B1 (en) * 2020-08-11 2022-02-22 Specialty Diagnostic (SDI) Laboratories, Inc. Method and system for classifying sample data for robotically extracted samples
CN112951230A (en) * 2021-02-08 2021-06-11 谈斯聪 Remote and autonomous experimental robot device, management system and method
EP4320267A1 (en) * 2021-04-07 2024-02-14 Seek Labs, Inc. Methods and systems for nucleic acid extraction
JP7421806B2 (en) * 2021-04-13 2024-01-25 株式会社パイプシェルナノセカンズ Execution information recording method, execution information recording device, program, recording medium, execution information transmission method, and execution information transmission device
CN113624985B (en) * 2021-08-16 2023-06-30 优爱宝智能机器人(浙江)有限公司 High-throughput sample adding processing device based on multi-joint or SCARA robot
WO2024043764A1 (en) * 2022-08-25 2024-02-29 주식회사 씨젠 Container position indicating device and assembly-type diagnostic system using same

Family Cites Families (202)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1198488A (en) * 1966-08-23 1970-07-15 Hans Peter Olof Unger Improvements in or relating to Automated Analysis
US4002909A (en) * 1967-09-28 1977-01-11 Packard Instrument Company, Inc. Data analyzing system having provision for optimizing counting conditions and thus improving statistical counting validity for enabling accurate computation of sample activity levels in liquid scintillation spectrometry
US3627431A (en) * 1969-12-22 1971-12-14 John Victor Komarniski Densitometer
US3722719A (en) * 1970-04-10 1973-03-27 Packard Instrument Co Inc Method of and apparatus for sample vial transferring and changing
US3792276A (en) * 1971-10-12 1974-02-12 Packard Instrument Co Inc Method and apparatus for programming liquid scintillation spectrometers
US3898457A (en) * 1971-10-26 1975-08-05 Packard Instrument Co Inc Methods and apparatus for handling flexible liquid sample containers for scintillation spectrometry
US3773426A (en) * 1972-02-22 1973-11-20 Department Of Health Educ Welf Bacterial growth detector
US3844428A (en) * 1972-04-07 1974-10-29 Packard Instrument Co Inc Tray storage and handling system for scintillation spectrometers and the like
US3899673A (en) * 1972-05-24 1975-08-12 Packard Instrument Co Inc Data processing system employing quench simulation for enabling accurate computation of sample activity levels in liquid scintillation spectrometry
US3857485A (en) * 1972-06-05 1974-12-31 Packard Instrument Co Inc Flexible containers for liquid sample spectrometry and methods and apparatus for forming, filling and handling the same
US3924128A (en) * 1972-06-05 1975-12-02 Packard Instrument Co Inc Apparatus for handling flexible containers for liquid sample spectrometry
CA1024425A (en) * 1972-11-17 1978-01-17 William E. Cunningham Automatic determination of the concentration of bacteria in liquids
US3988240A (en) 1973-04-05 1976-10-26 The United States Of America As Represented By The Secretary Of The Interior Alternating field magnetic separator
US3885879A (en) * 1973-06-25 1975-05-27 Fisher Scientific Co Dual beam spectrophotometer utilizing a spectral wedge and bifurcated fiber optic bundle
US3852599A (en) * 1973-07-09 1974-12-03 Packard Instrument Co Inc Vial transfer mechanism
US3890505A (en) * 1973-07-27 1975-06-17 Packard Instrument Co Inc Scintillation counter; photomultiplier tube alignment
US3883742A (en) * 1973-07-27 1975-05-13 Packard Instrument Co Inc Scintillation counter, segmented shield
US4004150A (en) * 1975-05-01 1977-01-18 Samuel Natelson Analytical multiple component readout system
US4115010A (en) * 1976-02-03 1978-09-19 Merck & Co., Inc. Automated plate reader
FR2368709A1 (en) * 1976-10-19 1978-05-19 Pasteur Institut AUTOMATIC PHOTOMETER
US4147250A (en) * 1977-03-25 1979-04-03 Packard Instrument Company, Inc. Storage and indexing mechanism for multiple sample containers
US4101174A (en) * 1977-03-25 1978-07-18 Continental Oil Company Slurry control system
FI59934C (en) * 1978-07-05 1981-11-10 Suovaniemi Finnpipette FOERFLYTTNINGSANORDNING FOER ANALYSANLAEGGNINGAR
US4240751A (en) * 1978-11-09 1980-12-23 Akzona Incorporated Method and apparatus for specific binding substances
JPS55136958A (en) * 1979-04-14 1980-10-25 Olympus Optical Co Ltd Automatic analyzer
JPS55156840A (en) * 1979-05-25 1980-12-06 Olympus Optical Co Ltd Specimen detector
US4349510A (en) * 1979-07-24 1982-09-14 Seppo Kolehmainen Method and apparatus for measurement of samples by luminescence
EP0030086B2 (en) * 1979-11-13 1990-03-14 TECHNICON INSTRUMENTS CORPORATION (a New York corporation) Test-tube assembly, kit for making it and method of manual immunoassay
JPS56164958A (en) 1980-05-23 1981-12-18 Aloka Co Ltd Automatic dispenser
US4340390A (en) * 1980-06-16 1982-07-20 Eastman Kodak Company Method and apparatus for metering biological fluids
US4358203A (en) * 1980-12-10 1982-11-09 Becton Dickinson And Company Apparatus for analyzing and evaluating tests in a plurality of wells
JPS57132038A (en) * 1981-02-10 1982-08-16 Olympus Optical Co Ltd Photometric device
JPS57182651A (en) * 1981-05-07 1982-11-10 Olympus Optical Co Ltd Detection apparatus of particle agglomeration pattern
US4498782A (en) * 1981-05-29 1985-02-12 Science Research Center, Inc. Assembly for determining light transmissiveness of a fluid
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
US4431307A (en) * 1981-11-19 1984-02-14 Labsystems Oy Set of cuvettes
DE3279029D1 (en) * 1981-12-11 1988-10-20 Welsh Nat School Med Luminescent labelling materials and procedures
JPS58105065A (en) * 1981-12-17 1983-06-22 Olympus Optical Co Ltd Analyzer based on emmunological agglutination
US4483825A (en) * 1982-07-09 1984-11-20 Fatches Keith R Pipette and filter combination
US4472352A (en) * 1982-09-24 1984-09-18 Biosys S.A. Device for biochemical quantitative analysis of successive samples
US4557726A (en) * 1982-12-27 1985-12-10 Consolidated Controls Corporation Precision medication dispensing system and method
US5500188A (en) * 1984-03-01 1996-03-19 Molecular Devices Corporation Device for photoresponsive detection and discrimination
US5112134A (en) * 1984-03-01 1992-05-12 Molecular Devices Corporation Single source multi-site photometric measurement system
US4968148A (en) * 1984-03-01 1990-11-06 Molecular Devices Corporation Single source multi-site photometric measurement system
JPS60206028A (en) 1984-03-30 1985-10-17 Hitachi Ltd Plasma control apparatus
US4794085A (en) * 1984-07-19 1988-12-27 Eastman Kodak Company Apparatus and method for detecting liquid penetration by a container used for aspirating and dispensing the liquid
IT1177253B (en) * 1984-11-19 1987-08-26 Instrumentation Lab Spa ANALYTICAL PHOTOMETER, IN PARTICULAR MULTI-CHANNEL APPLIED TO A CENTRIFUGAL SYSTEM FOR THE PRACTICALLY SIMULTANEOUS DETERMINATION OF THE PRESENCE OF DIFFERENT SUBSTANCES IN A CERTAIN NUMBER OF SAMPLES
IL77144A (en) * 1984-11-27 1991-04-15 Orgenics Ltd Method and apparatus for performing solid phase immuno-assay on test card in a plurality of samples
US4772453A (en) * 1985-03-01 1988-09-20 Lisenbee Wayne F Luminiscence measurement arrangement
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5656493A (en) 1985-03-28 1997-08-12 The Perkin-Elmer Corporation System for automated performance of the polymerase chain reaction
US5146093A (en) * 1985-04-08 1992-09-08 Packard Instrument Company, Inc. Liquid scintillation measurement system with active guard shield
US4651006A (en) * 1985-04-08 1987-03-17 Packard Instrument Company, Inc. Reduced background scintillation counting
DE3513086A1 (en) * 1985-04-12 1986-10-16 Robert Bosch Gmbh, 7000 Stuttgart DEVICE FOR AN INTERNAL COMBUSTION ENGINE FOR INFLUENCING OPERATING PARAMETERS
JPS61241639A (en) * 1985-04-19 1986-10-27 Hitachi Ltd Reactive sample analyzing instrument
US4751177A (en) * 1985-06-13 1988-06-14 Amgen Methods and kits for performing nucleic acid hybridization assays
JPS6264912A (en) 1985-09-17 1987-03-24 Minoru Atake Distributive injection apparatus
US4737464A (en) * 1985-09-26 1988-04-12 Molecular Devices Corporation Solid-state optical assay imaging apparatus
US4730921A (en) * 1985-10-31 1988-03-15 Genetic Systems, Inc. Photodensitometer for minimizing the refractive effects of a fluid sample
US4672200A (en) * 1985-11-05 1987-06-09 Emhart Industries, Inc. Optical inspection of transparent layers
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4778451A (en) * 1986-03-04 1988-10-18 Kamen Dean L Flow control system using boyle's law
GB8607975D0 (en) * 1986-04-01 1986-05-08 Fisons Plc Devices
SE8601528D0 (en) 1986-04-07 1986-04-07 Leo Ab MIXING APPARATUS AND METHOD
US4864856A (en) * 1986-07-14 1989-09-12 Fuji Photo Film Co., Ltd. Liquid level detecting device
JPS6329251A (en) * 1986-07-23 1988-02-06 Takeda Chem Ind Ltd Method and instrument for automatic analysis of enzyme reaction
JPS6329253A (en) * 1986-07-23 1988-02-06 Takeda Chem Ind Ltd Automatic dilution and reaction device
ATE88762T1 (en) 1986-08-11 1993-05-15 Siska Diagnostics Inc METHODS AND COMPOSITIONS FOR TESTING WITH NUCLEIC ACID PROBES.
JPS6375565A (en) * 1986-09-18 1988-04-05 Toshiba Corp Sampling monitor
US5750338A (en) * 1986-10-23 1998-05-12 Amoco Corporation Target and background capture methods with amplification for affinity assays
US5714380A (en) * 1986-10-23 1998-02-03 Amoco Corporation Closed vessel for isolating target molecules and for performing amplification
ZA877772B (en) 1986-10-23 1988-04-20 Amoco Corporation Target and background capture methods and apparatus for affinity assays
DE3720733A1 (en) * 1987-03-31 1988-10-13 Lufthansa Service Gmbh METHOD FOR THE MICROBIOLOGICAL EXAMINATION OF SAMPLES
CA1321940C (en) * 1987-05-02 1993-09-07 Teruaki Itoh Apparatus for distributing sample liquid
US4800750A (en) * 1987-06-10 1989-01-31 Goran Enhorning Device for accurately displacing fluid
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Method and kits for the amplification and detection of nucleic acid sequences
EP0365595A4 (en) 1987-06-26 1990-06-05 Du Pont Affinity removal of contaminating sequences from recombinant cloned na using capture beads.
JP2774121B2 (en) 1987-07-31 1998-07-09 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ Selective amplification of target polynucleotide sequence
JPS6438636A (en) * 1987-08-05 1989-02-08 Ajinomoto Kk Fluorescent analyzer
JPH01145552A (en) * 1987-12-02 1989-06-07 Olympus Optical Co Ltd Automatic apparatus for analysis
US4895650A (en) 1988-02-25 1990-01-23 Gen-Probe Incorporated Magnetic separation rack for diagnostic assays
US4950613A (en) * 1988-02-26 1990-08-21 Gen-Probe Incorporated Proteted chemiluminescent labels
US4929828A (en) * 1988-02-29 1990-05-29 Emhart Industries, Inc. Inspecting glass containers for line-over finish defects with bifurcated fiber optic bundle
US4846003A (en) * 1988-06-08 1989-07-11 Beckman Instruments, Inc. Acoustic impedance system for pipette tip detection
US4892409A (en) * 1988-07-14 1990-01-09 Smith Harry F Photometric apparatus for multiwell plates having a positionable lens assembly
US5281540A (en) * 1988-08-02 1994-01-25 Abbott Laboratories Test array for performing assays
US5320808A (en) * 1988-08-02 1994-06-14 Abbott Laboratories Reaction cartridge and carousel for biological sample analyzer
US5075077A (en) * 1988-08-02 1991-12-24 Abbott Laboratories Test card for performing assays
JP2656564B2 (en) * 1988-08-26 1997-09-24 株式会社日立製作所 Immunoassay method
US5325295A (en) * 1989-05-04 1994-06-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adaptation of microtiter plate technology to measurement of platelet aggregation
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5281394A (en) * 1989-07-21 1994-01-25 Icn Biomedicals, Inc. Data collection and sample handling apparatus
US5192692A (en) * 1989-07-25 1993-03-09 Olympus Optical Co., Ltd. Method of judging particle agglutination pattern
US5124041A (en) * 1989-07-28 1992-06-23 Applied Biosystems, Inc. Biomolecule sample immobilization
EP0416148A1 (en) * 1989-09-07 1991-03-13 RSM ANALYTISCHE INSTRUMENTE GmbH Arrangement for simultaneously measuring particle or quantum radiation from multiple samples
US5198670A (en) * 1989-09-29 1993-03-30 Packard Instrument Company Scintillation counting system for in-situ measurement of radioactive samples in a multiple-well plate
GB8927744D0 (en) 1989-12-07 1990-02-07 Diatec A S Process and apparatus
US5427930A (en) 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
US5195282A (en) * 1990-01-29 1993-03-23 Campbell E Logan Low cost-modular element housing
GB9003253D0 (en) 1990-02-13 1990-04-11 Amersham Int Plc Precipitating polymers
US5073029A (en) * 1990-02-16 1991-12-17 Eqm Research, Inc. Multisource device for photometric analysis and associated chromogens
US5139745A (en) * 1990-03-30 1992-08-18 Block Medical, Inc. Luminometer
WO1991016675A1 (en) * 1990-04-06 1991-10-31 Applied Biosystems, Inc. Automated molecular biology laboratory
DE4013586C2 (en) * 1990-04-27 1994-08-18 Suzuki Motor Co Device for the detection of immunological agglutination
US5252296A (en) * 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
JPH0678978B2 (en) * 1990-05-25 1994-10-05 スズキ株式会社 Aggregation pattern detector
US5114858A (en) * 1990-06-26 1992-05-19 E. I. Du Pont De Nemours And Company Cellular component extraction process in a disposable filtration vessel
JPH0477669A (en) * 1990-07-20 1992-03-11 Nittec Co Ltd Automatic analyzer
FI86340C (en) * 1990-10-31 1992-08-10 Labsystems Oy Procedure for conducting light
US5463895A (en) 1990-11-09 1995-11-07 Abbott Laboratories Sample pipetting method
JP3065100B2 (en) 1990-11-09 2000-07-12 アボット・ラボラトリーズ Sample pipetting method
US5133392A (en) * 1991-04-10 1992-07-28 Eastman Kodak Company Liquid injection using container bottom sensing
US5240856A (en) 1991-10-23 1993-08-31 Cellpro Incorporated Apparatus for cell separation
SE469198B (en) 1991-10-29 1993-05-24 Perstorp Analytical Ab LUMINOMETERANORDNING
US5304492A (en) * 1991-11-26 1994-04-19 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Spectrophotometer for chemical analyses of fluids
JPH05157684A (en) * 1991-12-02 1993-06-25 Seikagaku Kogyo Co Ltd Absorptionmeter
US5304130A (en) * 1992-02-26 1994-04-19 Baxter International Inc. Container for the controlled administration of a beneficial agent
JP2725940B2 (en) * 1992-03-03 1998-03-11 アロカ株式会社 Dispensing device
US5376313A (en) * 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
JP4137996B2 (en) 1992-05-06 2008-08-20 ジェン−プローブ・インコーポレイテッド Nucleic acid sequence amplification method, composition and kit
US5319436A (en) * 1992-05-28 1994-06-07 Packard Instrument Company, Inc. Microplate farming wells with transparent bottom walls for assays using light measurements
EP0642592A4 (en) 1992-05-29 1997-01-02 Abbott Lab Ligase chain reaction starting with rna sequences.
US5314825A (en) * 1992-07-16 1994-05-24 Schiapparelli Biosystems, Inc. Chemical analyzer
US5270210A (en) * 1992-07-16 1993-12-14 Schiapparelli Biosystems, Inc. Capacitive sensing system and wash/alignment station for a chemical analyzer
CA2100020C (en) 1992-07-17 2001-09-11 Walter Blumenfeld Methods and apparatus for detecting bacterial growth by spectrophotometric sampling of a fiber-optic array
US5714127A (en) * 1992-10-08 1998-02-03 Warner-Lambert Company System for multiple simultaneous synthesis
WO1994008759A1 (en) * 1992-10-16 1994-04-28 Thomas Jefferson University Method and apparatus for robotically performing sanger dideoxynucleotide dna sequencing reactions
US5508200A (en) * 1992-10-19 1996-04-16 Tiffany; Thomas Method and apparatus for conducting multiple chemical assays
US5298753A (en) * 1992-11-12 1994-03-29 Wallac Oy Arrangement for counting liquid scintillation samples on bottom-window multi-well sample plates
US5538849A (en) * 1992-12-29 1996-07-23 Toyo Boseki Kabushiki Kaisha Apparatus for automated assay of DNA probe and method for assaying nucleic acid in sample
AU687363B2 (en) 1993-03-19 1998-02-26 Ciba Corning Diagnostics Corp. Luminometer
US5342581A (en) * 1993-04-19 1994-08-30 Sanadi Ashok R Apparatus for preventing cross-contamination of multi-well test plates
US5407638A (en) * 1993-04-28 1995-04-18 Shell Oil Company Detector-cell adapted for continuous-flow absorption detection
US5483347A (en) * 1993-05-19 1996-01-09 Hughes Aircraft Company Non-contact measurement apparatus using bifurcated optical fiber bundle with intermixed fibers
US5468453A (en) 1993-06-14 1995-11-21 Cirrus Diagnostics, Inc. Low carryover pipette probe
JP3318629B2 (en) * 1993-06-18 2002-08-26 ソニー株式会社 Liquid suction / discharge device and method
CA2129787A1 (en) 1993-08-27 1995-02-28 Russell G. Higuchi Monitoring multiple amplification reactions simultaneously and analyzing same
US5540081A (en) 1993-08-31 1996-07-30 Abbott Laboratories Pipetting apparatus with clot detection
EP0724483A1 (en) * 1993-10-22 1996-08-07 Abbott Laboratories Reaction tube and method of use to minimize contamination
US5451373A (en) * 1994-02-16 1995-09-19 Akzo N.V. Obstruction detector for a fluid flow line of a medical laboratory instrument
JP3351615B2 (en) * 1994-03-17 2002-12-03 ソニー株式会社 Liquid boundary detection method and liquid separation method
US5547861A (en) * 1994-04-18 1996-08-20 Becton, Dickinson And Company Detection of nucleic acid amplification
AU698953B2 (en) 1994-04-29 1998-11-12 Applied Biosystems, Llc System for real time detection of nucleic acid amplification products
US5496523A (en) * 1994-05-06 1996-03-05 Sorenson Bioscience Filtered micropipette tip for high/low volume pipettors
US5503036A (en) * 1994-05-09 1996-04-02 Ciba Corning Diagnostics Corp. Obstruction detection circuit for sample probe
WO1995031726A1 (en) 1994-05-11 1995-11-23 Genera Technologies Limited Methods of capturing species from liquids and assay procedures
US5686271A (en) 1994-06-09 1997-11-11 Gamera Bioscience Corporation Apparatus for performing magnetic cycle reaction
US5567326A (en) 1994-09-19 1996-10-22 Promega Corporation Multisample magnetic separation device
US5490971A (en) * 1994-10-25 1996-02-13 Sippican, Inc. Chemical detector
US5814275A (en) 1995-02-15 1998-09-29 Akzo Nobel N.V. Obstruction detector for a fluid flow line of a medical laboratory instrument
EP0810905B1 (en) * 1995-02-21 1998-11-04 Iqbal W. Dr. Siddiqi Apparatus and method for mixing and separation employing magnetic particles
US5895631A (en) * 1995-03-20 1999-04-20 Precision System Science Co., Ltd. Liquid processing method making use of pipette device and apparatus for same
US5578270A (en) * 1995-03-24 1996-11-26 Becton Dickinson And Company System for nucleic acid based diagnostic assay
US5604130A (en) * 1995-05-31 1997-02-18 Chiron Corporation Releasable multiwell plate cover
US5518923A (en) * 1995-06-06 1996-05-21 Becton Dickinson And Company Compact blood culture apparatus
US5918291A (en) * 1995-06-07 1999-06-29 Inacu; Fulga Method for liquid aspiration from a sealed container
US5537880A (en) * 1995-06-07 1996-07-23 Abbott Laboratories Automatic pipetting apparatus with leak detection and method of detecting a leak
US6158269A (en) 1995-07-13 2000-12-12 Bayer Corporation Method and apparatus for aspirating and dispensing sample fluids
US5750881A (en) 1995-07-13 1998-05-12 Chiron Diagnostics Corporation Method and apparatus for aspirating and dispensing sample fluids
US5550025A (en) 1995-07-19 1996-08-27 Becton, Dickinson And Company Detection of hydrophobic amplification products by extraction into an organic phase
EP0862647A1 (en) 1995-11-03 1998-09-09 Sarnoff Corporation Assay system and method for conducting assays
US5723795A (en) * 1995-12-14 1998-03-03 Abbott Laboratories Fluid handler and method of handling a fluid
US5915282A (en) * 1995-12-14 1999-06-22 Abbott Laboratories Fluid handler and method of handling a fluid
US5965828A (en) 1995-12-14 1999-10-12 Abbott Laboratories Fluid handler and method of handling a fluid
US6100079A (en) * 1996-02-25 2000-08-08 Precision System Science Co., Ltd. Method for treating biopolymers, microorganisms or materials by using more than one type of magnetic particles
CA2173315C (en) 1996-04-02 2000-01-04 W. John Mcdonald Method and apparatus for magnetic treatment of liquids
US6083762A (en) 1996-05-31 2000-07-04 Packard Instruments Company Microvolume liquid handling system
EP0810438B1 (en) 1996-05-31 2004-02-04 Packard Instrument Company, Inc. Microvolume liquid handling system
US6008055A (en) 1998-06-30 1999-12-28 Transgenomic, Inc. Modular component fiber optic fluorescence detector system, and method of use
US5882903A (en) * 1996-11-01 1999-03-16 Sarnoff Corporation Assay system and method for conducting assays
US5851491A (en) 1997-06-13 1998-12-22 Labcon, North America Pipette tip and filter for accurate sampling and prevention of contamination
US6043880A (en) * 1997-09-15 2000-03-28 Becton Dickinson And Company Automated optical reader for nucleic acid assays
US5853665A (en) 1997-09-16 1998-12-29 Coulter International Corp. Apparatus and method for monitoring vent line vacuum
EP1712921A2 (en) 1997-09-29 2006-10-18 F.Hoffmann-La Roche Ag Apparatus for separating magnetic particles
JP3062481B2 (en) 1997-11-19 2000-07-10 グルポ グリフォルス,エス.エー. Equipment for automatic laboratory testing
US6121049A (en) 1997-12-05 2000-09-19 Bayer Corporation Method of verifying aspirated volume in automatic diagnostic system
US6060320A (en) * 1997-12-05 2000-05-09 Bayer Corporation Method of verifying aspirated volume in automatic diagnostic system
DE10011555T1 (en) 1998-05-01 2012-02-02 Gen-Probe Inc. Automatic diagnostic analyzer and method
AU4368699A (en) * 1998-05-29 1999-12-20 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. New method for transferring biological material
US6022747A (en) * 1998-07-10 2000-02-08 Bayer Corporation Blood clot detector
ATE303598T1 (en) * 1998-07-31 2005-09-15 Tecan Trading Ag MAGNETIC SEPARATOR
US6413780B1 (en) * 1998-10-14 2002-07-02 Abbott Laboratories Structure and method for performing a determination of an item of interest in a sample
US5973138A (en) 1998-10-30 1999-10-26 Becton Dickinson And Company Method for purification and manipulation of nucleic acids using paramagnetic particles
US6216049B1 (en) * 1998-11-20 2001-04-10 Becton, Dickinson And Company Computerized method and apparatus for analyzing nucleic acid assay readings
JP2002534985A (en) * 1999-01-19 2002-10-22 ソマロジック・インコーポレーテッド Methods and apparatus for automated generation of nucleic acid ligands
US6296702B1 (en) * 1999-03-15 2001-10-02 Pe Corporation (Ny) Apparatus and method for spotting a substrate
US6245297B1 (en) * 1999-04-16 2001-06-12 Pe Corporation (Ny) Apparatus and method for transferring small volumes of substances
ATE232418T1 (en) * 1999-05-27 2003-02-15 Pe Corp Ny APPARATUS AND METHOD FOR PRECISE LOCATION OF REACTION PLATES
AU6281200A (en) * 1999-08-09 2001-03-05 Bilatec Ag Laboratory robot and method and reagent kit for isolating nucleic acids
WO2001031317A1 (en) * 1999-10-26 2001-05-03 Genometrix Genomics Incorporated Method and apparatus for selectively retrieving biological samples for processing
JP4071907B2 (en) * 1999-11-29 2008-04-02 オリンパス株式会社 Automatic nucleic acid testing equipment
JP2001169771A (en) * 1999-12-15 2001-06-26 Olympus Optical Co Ltd Automatically pipetting unit
US6936414B2 (en) * 1999-12-22 2005-08-30 Abbott Laboratories Nucleic acid isolation method and kit
ES2319101T3 (en) * 2000-05-19 2009-05-04 Becton Dickinson And Company SYSTEM AND PROCEDURE FOR MAGNETICALLY SENSITIVE PARTICLE HANDLING IN FLUID SAMPLES TO EXTRACT DNA OR RNA FROM A SAMPLE.
US6672458B2 (en) * 2000-05-19 2004-01-06 Becton, Dickinson And Company System and method for manipulating magnetically responsive particles fluid samples to collect DNA or RNA from a sample
KR100391200B1 (en) 2000-08-02 2003-07-12 기아자동차주식회사 a deburring machine for work
JP2002098704A (en) * 2000-09-25 2002-04-05 Olympus Optical Co Ltd Autoanalyzer of bacteria
WO2002031747A1 (en) * 2000-10-13 2002-04-18 Irm Llc High throughput processing system and method of using
US20040149015A1 (en) 2002-02-13 2004-08-05 Hansen Timothy R. System and method for verifying the integrity of the condition and operation of a pipetter device for manipulating fluid samples
US20040157219A1 (en) 2003-02-06 2004-08-12 Jianrong Lou Chemical treatment of biological samples for nucleic acid extraction and kits therefor

Also Published As

Publication number Publication date
WO2003097808A3 (en) 2004-07-15
US20110200991A1 (en) 2011-08-18
WO2003097808A2 (en) 2003-11-27
ES2594333T3 (en) 2016-12-19
RU2004137103A (en) 2005-11-20
EP1506413B1 (en) 2016-07-06
CA2483694A1 (en) 2003-11-27
CA2483694C (en) 2016-04-19
US20040029260A1 (en) 2004-02-12
BR0310060A (en) 2005-02-15
CN103399162A (en) 2013-11-20
JP2005525816A (en) 2005-09-02
JP4532264B2 (en) 2010-08-25
EP1506413A2 (en) 2005-02-16
KR20050008720A (en) 2005-01-21
US20090155808A1 (en) 2009-06-18
AU2003233555A1 (en) 2003-12-02
US9696328B2 (en) 2017-07-04
BRPI0310060B1 (en) 2017-01-31
CN1653338A (en) 2005-08-10
US20120282603A1 (en) 2012-11-08
MXPA04011083A (en) 2005-02-14
EP1506413A4 (en) 2005-08-17
AU2003233555B2 (en) 2009-11-26
ZA200409089B (en) 2005-02-08
BRPI0310060B8 (en) 2021-07-27
NO20045307L (en) 2004-12-03
CN103399162B (en) 2016-04-27

Similar Documents

Publication Publication Date Title
US9696328B2 (en) Automated system for isolating, amplifying and detecting a target nucleic acid sequence
US11549959B2 (en) Automated pipetting apparatus having a combined liquid pump and pipette head system
US11098343B2 (en) Systems and methods for performing assays
EP3430410B1 (en) Method for automated analysis
JP5642551B2 (en) Automatic analyzers for clinical laboratories
JP5038004B2 (en) Analysis equipment
JP4656646B2 (en) Display method, display device, and fully automatic inspection device provided with the display device
JP2005523692A (en) Structures and methods for treating magnetic particles in biological assays
EP2884285A1 (en) Supply module for an automated analyzer
JP5846773B2 (en) Sample distribution
CN111575172A (en) Gene detection system
EP1615037A1 (en) An apparatus for liquid handling with multiple transfer tools
CN212610645U (en) Gene detection system
CN115820402A (en) Automatic system for microbial testing and microbial testing method
CN113444625A (en) Automated nucleic acid detection system and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGES 1/21-21/21, DRAWINGS, REPLACED BY NEW PAGES 1/21-21/21; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/011083

Country of ref document: MX

REEP Request for entry into the european phase

Ref document number: 2003728991

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003728991

Country of ref document: EP

Ref document number: 2004/09089

Country of ref document: ZA

Ref document number: 200409089

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2483694

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020047018515

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 20038112485

Country of ref document: CN

Ref document number: 2004506467

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1762/KOLNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2003233555

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004137103

Country of ref document: RU

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1020047018515

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003728991

Country of ref document: EP